PLK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00139 | T554 | EPSD|PSP | KIF2A KIF2 KNS2 | MASCENTLNTLRYANRVKELtVDPTAAGDVRPIMHHPPNQI |
| O00410 | S827 | Sugiyama | IPO5 KPNB3 RANBP5 | NQELRQVKRQDEDyDEQVEEsLQDEDDNDVyILTKVSDILH |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O14641 | T206 | SIGNOR|EPSD|PSP | DVL2 | ERHLAGYESSSTLMTSELEStSLGDsDEEDTMSRFSSStEQ |
| O14920 | S733 | GPS6|SIGNOR|EPSD|PSP | IKBKB IKKB | HNLCTLLENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLE |
| O14920 | S740 | GPS6|SIGNOR|EPSD|PSP | IKBKB IKKB | ENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLEQAs____ |
| O14920 | S750 | GPS6|SIGNOR|EPSD|PSP | IKBKB IKKB | QDQsFTALDWsWLQTEEEEHsCLEQAs______________ |
| O14980 | T1030 | Sugiyama | XPO1 CRM1 | AFKEHLRDFLVQIKEFAGEDtsDLFLEEREIALRQADEEKH |
| O14981 | S261 | Sugiyama | BTAF1 TAF172 | EPEEKRRKIANVVINQsANDsKVLIDNIPDSSSLIEETNEW |
| O15350 | T27 | GPS6|SIGNOR|EPSD|PSP | TP73 P73 | TSPDGGTTFEHLWSSLEPDStyFDLPQSSRGNNEVVGGTDs |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O15392 | S20 | SIGNOR|EPSD|PSP | BIRC5 API4 IAP4 | _MGAPTLPPAWQPFLKDHRIstFKNWPFLEGCACtPERMAE |
| O15392 | T21 | EPSD|PSP | BIRC5 API4 IAP4 | MGAPTLPPAWQPFLKDHRIstFKNWPFLEGCACtPERMAEA |
| O43379 | S897 | EPSD|PSP | WDR62 C19orf14 | LDAQDLDCYFTPMKPESLENsILDSLEPQSLASLLSESESP |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43399 | S21 | Sugiyama | TPD52L2 | MDsAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGL |
| O43474 | S234 | SIGNOR|PSP | KLF4 EZF GKLF | PPQQPQPPGGGLMGKFVLKAsLsAPGsEYGsPsVIsVsKGs |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43663 | S615 | EPSD|PSP | PRC1 | GLQRELsKASKSDATsGILNstNIQs_______________ |
| O43663 | T616 | GPS6|EPSD|PSP | PRC1 | LQRELsKASKSDATsGILNstNIQs________________ |
| O43719 | S713 | Sugiyama | HTATSF1 | DEKLFEDDDsNEKLFDEEEDssEKLFDDsDERGTLGGFGSV |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60216 | S175 | PSP | RAD21 HR21 KIAA0078 NXP1 SCC1 | LQENDFGDFGMDDREIMREGsAFEDDDMLVstttsNLLLES |
| O60216 | S454 | PSP | RAD21 HR21 KIAA0078 NXP1 SCC1 | HQQRDVIDEPIIEEPsRLQEsVMEAsRTNIDESAMPPPPPQ |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60260 | S378 | SIGNOR|EPSD|PSP | PRKN PARK2 | LGCGFAFCRECKEAYHEGECsAVFEASGTTTQAYRVDERAA |
| O60285 | S476 | EPSD|PSP | NUAK1 ARK5 KIAA0537 OMPHK1 | PKQSATMPKKGILKKTQQREsGYYssPERsESsELLDSNDV |
| O60285 | S480 | EPSD|PSP | NUAK1 ARK5 KIAA0537 OMPHK1 | ATMPKKGILKKTQQREsGYYssPERsESsELLDSNDVMGSS |
| O60341 | S126 | EPSD|PSP | KDM1A AOF2 KDM1 KIAA0601 LSD1 | EGRRTsRRKRAKVEyREMDEsLANLsEDEyysEEERNAKAE |
| O60343 | S304 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASQPALTSSRVCFPERILEDsGFDEQQEFRsRCssVTGVQR |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60563 | S564 | SIGNOR|EPSD|PSP | CCNT1 | DPKHSSQTSNLAHKTYSLSssFsSSsSTRKRGPsEEtGGAV |
| O60566 | S676 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | CGtIysQtLsIKKLsPIIEDsREAtHSsGFsGSSAsVAstS |
| O60566 | T1008 | GPS6|SIGNOR|EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | KDGELWNKFFVRILNANDEAtVSVLGELAAEMNGVFDTTFQ |
| O60566 | T680 | SIGNOR|EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | ysQtLsIKKLsPIIEDsREAtHSsGFsGSSAsVAstSsIKC |
| O60566 | T792 | GPS6|SIGNOR|EPSD|PSP | BUB1B BUBR1 MAD3L SSK1 | YLICEDYKLFWVAPRNSAELtVIKVSSQPVPWDFYINLKLK |
| O60610 | S542 | Sugiyama | DIAPH1 DIAP1 | ALHSEKQQIATEKQDLEAEVsQLtGEVAKLTKELEDAKKEM |
| O60716 | S920 | Sugiyama | CTNND1 KIAA0384 | LDNNystPNERGDHNRtLDRsGDLGDMEPLKGttPLMQDEG |
| O60716 | T916 | Sugiyama | CTNND1 KIAA0384 | NtKsLDNNystPNERGDHNRtLDRsGDLGDMEPLKGttPLM |
| O60749 | S302 | Sugiyama | SNX2 TRG9 | LRMVNKAADAVNKMTIKMNEsDAWFEEKQQQFENLDQQLRK |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O75116 | T567 | Sugiyama | ROCK2 KIAA0619 | NQNSQISTEKVNQLQRQLDEtNALLRtESDTAARLRKTQAE |
| O75122 | S1027 | PSP | CLASP2 KIAA0627 | sMPtHssPRsRDyNPyNysDsIsPFNKsALKEAMFDDDADQ |
| O75122 | S1034 | PSP | CLASP2 KIAA0627 | PRsRDyNPyNysDsIsPFNKsALKEAMFDDDADQFPDDLsL |
| O75122 | S1053 | PSP | CLASP2 KIAA0627 | KsALKEAMFDDDADQFPDDLsLDHsDLVAELLKELSNHNER |
| O75122 | S1092 | PSP | CLASP2 KIAA0627 | ERVEERKIALYELMKLTQEEsFSVWDEHFKTILLLLLETLG |
| O75170 | S289 | EPSD|PSP | PPP6R2 KIAA0685 PP6R2 SAPS2 | TQVLLTLLETRRVGtEGLVDsFsQGLERSYAVSSSVLHGIE |
| O75170 | T10 | EPSD|PSP | PPP6R2 KIAA0685 PP6R2 SAPS2 | ___________MFWKFDLNTtSHVDKLLDKEHVTLQELMDE |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O76094 | S616 | Sugiyama | SRP72 | DQIGKGtQGAtAGAssELDAsKtVssPPtsPRPGsAAtVsA |
| O94901 | S138 | SIGNOR|PSP | SUN1 KIAA0810 UNC84A | HGGTVSLQDAVTRRPPVLDEsWIREQTTVDHFWGLDDDGDL |
| O95218 | S165 | Sugiyama | ZRANB2 ZIS ZNF265 | LKEVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNL |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95235 | S528 | GPS6|EPSD | KIF20A MKLP2 RAB6KIFL | VHAPPMQLGFPSLHSFIKEHsLQVsPsLEKGAKADTGLDDD |
| O95251 | S57 | SIGNOR|EPSD|PSP | KAT7 HBO1 HBOa MYST2 | RRSARVTRssARLsQssQDssPVRNLQsFGTEEPAYstRRV |
| O95271 | S978 | SIGNOR|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | PEALPTCFKPQATVVSASLIsPAStPSCLsAASsIDNLTGP |
| O95271 | T1128 | SIGNOR|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | LLDLAPEDKEYQSVEEEMQStIREHRDGGNAGGIFNRYNVI |
| O95271 | T839 | SIGNOR|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | VQKLCTPENINCRDTQGRNStPLHLAAGYNNLEVAEYLLEH |
| O95271 | T930 | SIGNOR|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | AAQKGRTQLCALLLAHGADPtMKNQEGQTPLDLATADDIRA |
| O95271 | T982 | SIGNOR|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | PTCFKPQATVVSASLIsPAStPSCLsAASsIDNLTGPLAEL |
| O95425 | S238 | SIGNOR|EPSD|PSP|Sugiyama | SVIL | HDLsPAAEsssTFsFSGRDssFtEVPRsPKHAHSssLQQAA |
| O95433 | T20 | Sugiyama | AHSA1 C14orf3 HSPC322 | _MAKWGEGDPRWIVEERADAtNVNNWHWtERDASNWSTDKL |
| O95613 | S1235 | EPSD|PSP | PCNT KIAA0402 PCNT2 | LPELDRtLSECAEMSSVAEIsSHMREsFLMsPESVRECEQP |
| O95613 | S1241 | EPSD|PSP | PCNT KIAA0402 PCNT2 | tLSECAEMSSVAEIsSHMREsFLMsPESVRECEQPIRRVFQ |
| O95613 | T1209 | EPSD|PSP | PCNT KIAA0402 PCNT2 | LCLDDAGAGLALSTAPALEEtWSDVALPELDRtLSECAEMS |
| O95613 | T1221 | EPSD|PSP | PCNT KIAA0402 PCNT2 | STAPALEEtWSDVALPELDRtLSECAEMSSVAEIsSHMREs |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O96017 | S164 | EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | FRIFREVGPKNSyIAYIEDHsGNGTFVNTELVGKGKRRPLN |
| O96017 | S210 | EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | ALSLSRNKVFVFFDLtVDDQsVYPKALRDEYIMSKtLGSGA |
| O96017 | T205 | EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NNSEIALSLSRNKVFVFFDLtVDDQsVYPKALRDEYIMSKt |
| O96017 | T26 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CHEK2 CDS1 CHK2 RAD53 | DVEAQQSHGSSACsQPHGSVtQsQGSSsQsQGISSSSTSTM |
| O96017 | T68 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NSsQSSHSSSGTLSsLETVStQELYsIPEDQEPEDQEPEEP |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05556 | S503 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | TFECGACRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSE |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P05787 | S475 | Sugiyama | KRT8 CYK8 | TSSSRAVVVKKIETRDGKLVsEssDVLPK____________ |
| P06400 | S758 | PSP | RB1 | TFKRVLIKEEEYDSIIVFYNsVFMQRLKtNILQyAstRPPt |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06748 | S4 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NPM1 NPM | _________________MEDsMDMDMsPLRPQNyLFGCELK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S68 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRt |
| P07900 | S72 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRtLtIV |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07942 | S448 | Sugiyama | LAMB1 | CKLNVEGEHCDVCKEGFyDLssEDPFGCKSCACNPLGTIPG |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S63 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERt |
| P08238 | S67 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERtLtLV |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08621 | S410 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | DEARGGGGGQDNGLEGLGNDsRDMYMESEGGDGYLAPENGY |
| P08670 | S339 | PSP | VIM | YRRQVQsLtCEVDALKGtNEsLERQMREMEENFAVEAANyQ |
| P08670 | S459 | PSP|Sugiyama | VIM | KRTLLIKtVEtRDGQVINEtsQHHDDLE_____________ |
| P08670 | S56 | EPSD|PSP | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P08670 | S83 | SIGNOR|EPSD|PSP | VIM | tRssAVRLRssVPGVRLLQDsVDFsLADAINTEFKNTRTNE |
| P08670 | T327 | PSP | VIM | DALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMREM |
| P08670 | T336 | PSP | VIM | STEYRRQVQsLtCEVDALKGtNEsLERQMREMEENFAVEAA |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | S136 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | sRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVVL |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09960 | S486 | Sugiyama | LTA4H LTA4 | TNACIALSQRWITAKEDDLNsFNAtDLKDLsSHQLNEFLAQ |
| P09960 | T490 | Sugiyama | LTA4H LTA4 | IALSQRWITAKEDDLNsFNAtDLKDLsSHQLNEFLAQtLQR |
| P09972 | T124 | Sugiyama | ALDOC ALDC | VVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGAD |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DMV8 | S631 | PSP | HSPA1A HSP72 HSPA1 HSX70 | yQGAGGPGPGGFGAQGPKGGsGsGPtIEEVD__________ |
| P0DMV8 | S633 | PSP | HSPA1A HSP72 HSPA1 HSX70 | GAGGPGPGGFGAQGPKGGsGsGPtIEEVD____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T105 | Sugiyama | HSPD1 HSP60 | DLKDKYKNIGAKLVQDVANNtNEEAGDGtttAtVLARSIAK |
| P11047 | S942 | Sugiyama | LAMC1 LAMB2 | GFYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITG |
| P11047 | T1127 | Sugiyama | LAMC1 LAMB2 | NNTLSSQISRLQNIRNTIEEtGNLAEQARAHVENTERLIEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11388 | S1337 | SIGNOR|EPSD|PSP | TOP2A TOP2 | PRRAATKTKFTMDLDsDEDFsDFDEKtDDEDFVPsDAsPPK |
| P11388 | S1525 | SIGNOR|EPSD|PSP | TOP2A TOP2 | AVAPRAKSVRAKKPIKYLEEsDEDDLF______________ |
| P11388 | T1343 | EPSD|PSP | TOP2A TOP2 | KTKFTMDLDsDEDFsDFDEKtDDEDFVPsDAsPPKtKTsPK |
| P11413 | T406 | SIGNOR | G6PD | KRNELVIRVQPNEAVyTKMMtKKPGMFFNPEESELDLTYGN |
| P11413 | T466 | SIGNOR | G6PD | CGSQMHFVRSDELREAWRIFtPLLHQIELEKPKPIPYIYGs |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11586 | S323 | Sugiyama | MTHFD1 MTHFC MTHFD | WMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREIGLLSE |
| P11717 | S1378 | Sugiyama | IGF2R MPRI | QYACPPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTG |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12270 | S2048 | Sugiyama | TPR | NHRAADsQNsGEGNtGAAEssFsQEVsREQQPSsASERQAP |
| P12270 | S2050 | Sugiyama | TPR | RAADsQNsGEGNtGAAEssFsQEVsREQQPSsASERQAPRA |
| P12830 | S146 | SIGNOR | CDH1 CDHE UVO | PPHQASVSGIQAELLTFPNSsPGLRRQKRDWVIPPISCPEN |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S135 | Sugiyama | PDIA4 ERP70 ERP72 | IPVAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsR |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13693 | S46 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TPT1 | GLCLEVEGKMVSRTEGNIDDsLIGGNASAEGPEGEGTEstV |
| P13693 | S64 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TPT1 | DDsLIGGNASAEGPEGEGTEstVITGVDIVMNHHLQETSFT |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13861 | Y105 | Sugiyama | PRKAR2A PKR2 PRKAR2 | DLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTDE |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | S108 | Sugiyama | PRKCSH G19P1 | PSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQ |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T522 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMA |
| P14635 | S126 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNB1 CCNB | EPEPVKEEKLsPEPILVDTAsPsPMETsGCAPAEEDLCQAF |
| P14635 | S128 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNB1 CCNB | EPVKEEKLsPEPILVDTAsPsPMETsGCAPAEEDLCQAFsD |
| P14635 | S133 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNB1 CCNB | EKLsPEPILVDTAsPsPMETsGCAPAEEDLCQAFsDVILAV |
| P14635 | S147 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNB1 CCNB | PsPMETsGCAPAEEDLCQAFsDVILAVNDVDAEDGADPNLC |
| P14854 | S52 | Sugiyama | COX6B1 COX6B | QNyLDFHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTD |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15374 | S126 | Sugiyama | UCHL3 | NNKDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRV |
| P15374 | S151 | Sugiyama | UCHL3 | PEERARyLENyDAIRVtHEtsAHEGQTEAPsIDEKVDLHFI |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15924 | S1259 | Sugiyama | DSP | LDRLSRENRDLKDEIVRLNDsILQATEQRRRAEENALQQKA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18031 | S286 | SIGNOR|EPSD|PSP | PTPN1 PTP1B | QLRFSYLAVIEGAKFIMGDSsVQDQWKELsHEDLEPPPEHI |
| P18031 | S393 | EPSD|PSP | PTPN1 PTP1B | RVVGGsLRGAQAAsPAKGEPsLPEKDEDHALSYWKPFLVNM |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20042 | T175 | Sugiyama | EIF2S2 EIF2B | DGIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMV |
| P21333 | S1029 | Sugiyama | FLNA FLN FLN1 | VGPSGAAVPCKVEPGLGADNsVVRFLPREEGPYEVEVTYDG |
| P22314 | S820 | Sugiyama | UBA1 A1S9T UBE1 | tPKsGVKIHVsDQELQsANAsVDDsRLEELKATLPsPDKLP |
| P22314 | S824 | Sugiyama | UBA1 A1S9T UBE1 | GVKIHVsDQELQsANAsVDDsRLEELKATLPsPDKLPGFKM |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22692 | S255 | Sugiyama | IGFBP4 IBP4 | VKLPGGLEPKGELDCHQLADsFRE_________________ |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P25490 | T39 | SIGNOR|EPSD|PSP | YY1 INO80S | EIVELHEIEVETIPVETIETtVVGEEEEEDDDDEDGGGGDH |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P25786 | S211 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | GLRALRETLPAEQDLttKNVsIGIVGKDLEFTIyDDDDVsP |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26639 | S70 | Sugiyama | TARS1 TARS | WPEyIytRLEMYNILKAEHDsILAEKAEKDSKPIKVTLPDG |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S156 | Sugiyama | YWHAQ | DDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLGLALNFSV |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30084 | S107 | Sugiyama | ECHS1 | LTGGDKAFAAGADIKEMQNLsFQDCySSKFLKHWDHLTQVK |
| P30101 | T437 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KELGEKLsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsP |
| P30260 | S426 | EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | NRKTKSKTNKGGITQPNINDsLEItKLDssIIsEGKIStIt |
| P30260 | S434 | GPS6|ELM|iPTMNet|EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | NKGGITQPNINDsLEItKLDssIIsEGKIStItPQIQAFNL |
| P30260 | S435 | EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | KGGITQPNINDsLEItKLDssIIsEGKIStItPQIQAFNLQ |
| P30260 | T205 | EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | TTQVPNHsLSHRQPEtVLTEtPQDtIELNRLNLEssNsKYS |
| P30260 | T209 | GPS6|ELM|iPTMNet|EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | PNHsLSHRQPEtVLTEtPQDtIELNRLNLEssNsKYSLNTD |
| P30260 | T430 | GPS6|ELM|iPTMNet|EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | KSKTNKGGITQPNINDsLEItKLDssIIsEGKIStItPQIQ |
| P30260 | T446 | GPS6|ELM|iPTMNet|EPSD|PSP | CDC27 ANAPC3 D0S1430E D17S978E | sLEItKLDssIIsEGKIStItPQIQAFNLQKAAAEGLMSLL |
| P30291 | S123 | SIGNOR | WEE1 | DEAGGGAEGDSWEEEGFGsSsPVKsPAAPyFLGssFsPVRC |
| P30291 | S53 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | WEE1 | CEEEEEEEEEEGSGHSTGEDsAFQEPDSPLPPARsPTEPGP |
| P30305 | S209 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | GEDKENDGFVFKMPWKPTHPsSTHALAEWAsRREAFAQRPs |
| P30305 | S291 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | FVDILESDLKDDDAVPPGMEsLISAPLVKTLEKEEEKDLVM |
| P30305 | S353 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | LKRLERPQDRDTPVQNKRRRsVtPPEEQQEAEEPKARVLRs |
| P30305 | S375 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | tPPEEQQEAEEPKARVLRsKsLCHDEIENLLDSDHRELIGD |
| P30305 | S397 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | CHDEIENLLDSDHRELIGDYsKAFLLQtVDGKHQDLKYISP |
| P30305 | S465 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | EYEGGHIKTAVNLPLERDAEsFLLKSPIAPCSLDKRVILIF |
| P30305 | S50 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | PGLLLGSHGLLGsPVRAAASsPVttLtQtMHDLAGLGSETP |
| P30305 | S513 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | RGPRMCRFIRERDRAVNDYPsLYYPEMYILKGGYKEFFPQH |
| P30305 | T127 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | SDAGLCMDSPSPMDPHMAEQtFEQAIQAASRIIRNEQFAIR |
| P30305 | T167 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | RRFQsMPVRLLGHsPVLRNItNsQAPDGRRKsEAGSGAAss |
| P30305 | T265 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | VEELsPLALGRFSLTPAEGDtEEDDGFVDILESDLKDDDAV |
| P30305 | T404 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | LLDSDHRELIGDYsKAFLLQtVDGKHQDLKYISPETMVALL |
| P30305 | T58 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | GLLGsPVRAAASsPVttLtQtMHDLAGLGSETPKSQVGTLL |
| P30307 | S198 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDC25C | KNPNLGEDQAEEIsDELMEFsLKDQEAKVSRsGLYRsPsMP |
| P30307 | S75 | EPSD|PSP | CDC25C | GDSANLsILsGGtPKRCLDLsNLSSGEITATQLTTSADLDE |
| P30622 | S1364 | EPSD|PSP | CLIP1 CYLN1 RSN | VEMMSEAALNGNGDDLNNYDsDDQEKQsKKKPRLFCDICDC |
| P30622 | S195 | SIGNOR|EPSD|PSP | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P30622 | S312 | SIGNOR|EPSD|PSP | CLIP1 CYLN1 RSN | KANAVRRVMATtsAsLKRsPsAssLsSMSSVASSVSSRPSR |
| P30626 | T155 | SIGNOR|EPSD|PSP | SRI | RLsPQAVNSIAKRYstNGKItFDDyIACCVKLRALtDSFRR |
| P31327 | S808 | Sugiyama | CPS1 | IGSSMKsVGEVMAIGRTFEEsFQKALRMCHPsIEGFTPRLP |
| P31327 | S863 | Sugiyama | CPS1 | LSEPSsTRIyAIAKAIDDNMsLDEIEKLTYIDKWFLYKMRD |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P33981 | S108 | SIGNOR|PSP | TTK MPS1 MPS1L1 | IGRYSQAIEALPPDKYGQNEsFARIQVRFAELKAIQEPDDA |
| P33981 | S214 | SIGNOR|PSP | TTK MPS1 MPS1L1 | LLSEEEKKNLSASTVLtAQEsFSGSLGHLQNRNNSCDSRGQ |
| P33981 | S291 | SIGNOR|PSP | TTK MPS1 MPS1L1 | FGRVPVNLLNsPDCDVKtDDsVVPCFMKRQTSRSECRDLVV |
| P33981 | S321 | SIGNOR|PSP | TTK MPS1 MPS1L1 | TSRSECRDLVVPGSKPsGNDsCELRNLKSVQNsHFKEPLVS |
| P33981 | S333 | SIGNOR|PSP | TTK MPS1 MPS1L1 | GSKPsGNDsCELRNLKSVQNsHFKEPLVSDEKsSELIITDS |
| P33981 | S345 | SIGNOR|PSP | TTK MPS1 MPS1L1 | RNLKSVQNsHFKEPLVSDEKsSELIITDSITLKNKtEssLL |
| P33981 | S362 | SIGNOR|PSP | TTK MPS1 MPS1L1 | DEKsSELIITDSITLKNKtEssLLAKLEEtKEyQEPEVPEs |
| P33981 | S363 | SIGNOR|PSP | TTK MPS1 MPS1L1 | EKsSELIITDSITLKNKtEssLLAKLEEtKEyQEPEVPEsN |
| P33981 | S37 | SIGNOR|PSP | TTK MPS1 MPS1L1 | MNKVRDIKNKFKNEDLtDELsLNKIsADttDNsGtVNQIMM |
| P33981 | T12 | SIGNOR|PSP | TTK MPS1 MPS1L1 | _________MESEDLsGRELtIDsIMNKVRDIKNKFKNEDL |
| P33981 | T210 | SIGNOR|PSP | TTK MPS1 MPS1L1 | QKKQLLSEEEKKNLSASTVLtAQEsFSGSLGHLQNRNNSCD |
| P33981 | T33 | SIGNOR|PSP | TTK MPS1 MPS1L1 | IDsIMNKVRDIKNKFKNEDLtDELsLNKIsADttDNsGtVN |
| P33981 | T371 | SIGNOR|PSP | TTK MPS1 MPS1L1 | TDSITLKNKtEssLLAKLEEtKEyQEPEVPEsNQKQWQSKR |
| P33981 | T458 | SIGNOR|PSP | TTK MPS1 MPS1L1 | PISTSKWFDPKSICKtPssNtLDDYMsCFRtPVVKNDFPPA |
| P33981 | T46 | SIGNOR|PSP | TTK MPS1 MPS1L1 | KFKNEDLtDELsLNKIsADttDNsGtVNQIMMMANNPEDWL |
| P33981 | T564 | SIGNOR|PSP | TTK MPS1 MPS1L1 | NEKKQIYAIKYVNLEEADNQtLDSYRNEIAYLNKLQQHsDK |
| P33981 | T594 | SIGNOR|PSP | TTK MPS1 MPS1L1 | YLNKLQQHsDKIIRLYDYEItDQYIYMVMECGNIDLNSWLK |
| P33981 | T676 | PSP | TTK MPS1 MPS1L1 | VDGMLKLIDFGIANQMQPDttsVVKDSQVGtVNYMPPEAIK |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | T365 | Sugiyama | HSPA4 APG2 HSPH2 | TRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILsP |
| P35222 | S60 | PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | TtTAPsLsGKGNPEEEDVDTsQVLyEWEQGFSQsFTQEQVA |
| P35222 | S718 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | LDIGAQGEPLGYRQDDPsyRsFHSGGYGQDALGMDPMMEHE |
| P35568 | S24 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | IRS1 | PPEsDGFSDVRKVGYLRKPKsMHKRFFVLRAAsEAGGPARL |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | T1146 | Sugiyama | MYH9 | sRNKAEKQKRDLGEELEALKtELEDtLDstAAQQELRSKRE |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1155 | Sugiyama | MYH9 | RDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKKT |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35613 | S278 | Sugiyama | BSG UNQ6505/PRO21383 | ITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQ |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35869 | S489 | SIGNOR | AHR BHLHE76 | LYPASSTSSTAPFENNFFNEsMNECRNWQDNTAPMGNDTIL |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36507 | S222 | EPSD|PSP | MAP2K2 MEK2 MKK2 PRKMK2 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGT |
| P36507 | S226 | EPSD|PSP | MAP2K2 MEK2 MKK2 PRKMK2 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGTHYSV |
| P37840 | S129 | GPS6|SIGNOR|EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P38398 | S1164 | EPSD|PSP | BRCA1 RNF53 | QVCSETPDDLLDDGEIKEDtsFAENDIKESsAVFSKsVQKG |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39687 | S27 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | IHLELRNRtPsDVKELVLDNsRsNEGKLEGLTDEFEELEFL |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P41227 | S213 | Sugiyama | NAA10 ARD1 ARD1A TE2 | ACREEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDs |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42695 | S1419 | PSP | NCAPD3 CAPD3 KIAA0056 | QESNGEIEHVTKRAIStPEKsISDVTFGAGVSYIGtPRtPs |
| P42898 | T549 | EPSD|PSP | MTHFR | LKKYELRVNYHLVNVKGENItNAPELQPNAVTWGIFPGREI |
| P43034 | S157 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | yEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADMTIKLW |
| P43490 | S180 | Sugiyama | NAMPT PBEF PBEF1 | TVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSS |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46531 | S1791 | SIGNOR|PSP | NOTCH1 TAN1 | EGFKVSEASKKKRREPLGEDsVGLKPLKNAsDGALMDDNQN |
| P46531 | S2439 | SIGNOR|PSP | NOTCH1 TAN1 | LGVSSAASGHLGRSFLSGEPsQADVQPLGPSSLAVHTILPQ |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46937 | S405 | Sugiyama | YAP1 YAP65 | FLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDT |
| P46937 | T77 | EPSD|PSP | YAP1 YAP65 | VRGDsEtDLEALFNAVMNPKtANVPQtVPMRLRKLPDsFFK |
| P47736 | S525 | SIGNOR|EPSD|PSP | RAP1GAP KIAA0474 RAP1GA1 | NIQEVQEKREsPPAGQKtPDsGHVSQEPKSENSStQssPEM |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49023 | S272 | GPS6 | PXN | QQQtRIsAssAtRELDELMAsLsDFKIQGLEQRADGERCWA |
| P49321 | S497 | Sugiyama | NASP | tEGsEEDDKENDKtEEMPNDsVLENKsLQENEEEEIGNLEL |
| P49327 | S2465 | Sugiyama | FASN FAS | LLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHRTLL |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49588 | T164 | Sugiyama | AARS1 AARS | AGLEADLECKQIWQNLGLDDtKILPGNMKDNFWEMGDtGPC |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49589 | S746 | Sugiyama | CARS1 CARS | KLFEAQEKLYKEyLQMAQNGsFQ__________________ |
| P49792 | S1613 | Sugiyama | RANBP2 NUP358 | KAPKSGFEGMFTKKEGQWDCsVCLVRNEASATKCIACQNPG |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49959 | S649 | SIGNOR|EPSD|PSP | MRE11 HNGS1 MRE11A | QQPSRNVTTKNYsEVIEVDEsDVEEDIFPTTSKTDQRWSST |
| P49959 | S688 | EPSD|PSP | MRE11 HNGS1 MRE11A | STSSSKIMsQsQVsKGVDFEssEDDDDDPFMNTSSLRRNRR |
| P50395 | T407 | Sugiyama | GDI2 RABGDIB | LVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGs |
| P50395 | T408 | Sugiyama | GDI2 RABGDIB | VPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsE |
| P50395 | T412 | Sugiyama | GDI2 RABGDIB | LGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFE |
| P50395 | T413 | Sugiyama | GDI2 RABGDIB | GtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFEE |
| P50416 | T370 | Sugiyama | CPT1A CPT1 | DGRLLKPREMEQQMQRILDNtsEPQPGEARLAALTAGDRVP |
| P50542 | S167 | Sugiyama | PEX5 PXR1 | EVTDPLSVSPARWAEEyLEQsEEKLWLGEPEGTATDRWYDE |
| P50570 | T642 | Sugiyama | DNM2 DYN2 | RAGVYPEKDQAENEDGAQENtFsMDPQLERQVETIRNLVDS |
| P50851 | S1247 | Sugiyama | LRBA BGL CDC4L LBA | DCHGsVSEAssEQKIAKLDVsNVAtDtERLELKAsPNVEAP |
| P50897 | S262 | Sugiyama | PPT1 CLN1 PPT | EWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVF |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51532 | S1380 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEI |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51587 | S193 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA2 FACD FANCD1 | GRQTPKHISESLGAEVDPDMsWSSSLATPPtLsstVLIVRN |
| P51587 | S205 | SIGNOR|EPSD|PSP | BRCA2 FACD FANCD1 | GAEVDPDMsWSSSLATPPtLsstVLIVRNEEASETVFPHDT |
| P51587 | S206 | SIGNOR|EPSD|PSP | BRCA2 FACD FANCD1 | AEVDPDMsWSSSLATPPtLsstVLIVRNEEASETVFPHDTT |
| P51587 | S239 | iPTMNet|EPSD | BRCA2 FACD FANCD1 | TVFPHDTTANVKSYFSNHDEsLKKNDRFIASVTDsENTNQR |
| P51587 | T203 | SIGNOR|EPSD|PSP | BRCA2 FACD FANCD1 | SLGAEVDPDMsWSSSLATPPtLsstVLIVRNEEASETVFPH |
| P51587 | T207 | SIGNOR|EPSD|PSP | BRCA2 FACD FANCD1 | EVDPDMsWSSSLATPPtLsstVLIVRNEEASETVFPHDTTA |
| P52565 | T7 | SIGNOR | ARHGDIA GDIA1 | ______________MAEQEPtAEQLAQIAAENEEDEHsVNy |
| P52565 | T91 | SIGNOR | ARHGDIA GDIA1 | VVTGLTLVCSSAPGPLELDLtGDLEsFKKQsFVLKEGVEYR |
| P52789 | S889 | Sugiyama | HK2 | PHFAKVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVAC |
| P52907 | S215 | Sugiyama | CAPZA1 | QVHYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENA |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P53350 | S450 | Sugiyama | PLK1 PLK | NSVGVLFNDSTRLILyNDGDsLQYIERDGTESYLTVSSHPN |
| P53350 | S71 | Sugiyama | PLK1 PLK | RRYVRGRFLGKGGFAKCFEIsDADTKEVFAGKIVPKSLLLK |
| P53350 | T210 | PSP | PLK1 PLK | VKIGDFGLATKVEYDGERKKtLCGtPNyIAPEVLSKKGHSF |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P54105 | T223 | Sugiyama | CLNS1A CLCI ICLN | AGVRtEDsIRDyEDGMEVDttPtVAGQFEDADVDH______ |
| P54274 | S435 | GPS6|SIGNOR|EPSD|PSP | TERF1 PIN2 TRBF1 TRF TRF1 | RTSVMLKDRWRTMKKLKLISsDsED________________ |
| P54646 | T172 | PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55010 | T235 | Sugiyama | EIF5 | RMDEISDHAKVLtLsDDLERtIEERVNILFDFVKKKKEEGV |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55072 | T76 | PSP | VCP HEL-220 HEL-S-70 | TVLLKGKKRREAVCIVLSDDtCSDEKIRMNRVVRNNLRVRL |
| P55884 | S185 | Sugiyama | EIF3B EIF3S9 | EEELLGDVLKDRPQEADGIDsVIVVDNVPQVGPDRLEKLKN |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P60484 | S380 | EPSD|PSP | PTEN MMAC1 TEP1 | SSsTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQI |
| P60484 | T382 | EPSD|PSP | PTEN MMAC1 TEP1 | sTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItK |
| P60484 | T383 | EPSD|PSP | PTEN MMAC1 TEP1 | TSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61769 | S75 | Sugiyama | B2M CDABP0092 HDCMA22P | IEVDLLKNGERIEKVEHsDLsFsKDWSFYLLYYTEFTPTEK |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T231 | Sugiyama | YWHAG | LNEDsyKDstLIMQLLRDNLtLWtsDQQDDDGGEGNN____ |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | S135 | SIGNOR|EPSD|PSP | RAN ARA24 OK/SW-cl.81 | IPIVLCGNKVDIKDRKVKAKsIVFHRKKNLQyyDIsAKSNy |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63146 | S148 | Sugiyama | UBE2B RAD6B UBCH1 | QLYQENKREYEKRVsAIVEQsWNDS________________ |
| P63167 | S14 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | _______MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNI |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S314 | Sugiyama | YBX1 NSEP1 YB1 | NPKPQDGKETKAADPPAENssAPEAEQGGAE__________ |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P78371 | T475 | Sugiyama | CCT2 99D8.1 CCTB | GYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGITE |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78527 | S3205 | PSP | PRKDC HYRC HYRC1 | NRCFFLSKIEEKLtPLPEDNsMNVDQDGDPsDRMEVQEQEE |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00613 | S216 | SIGNOR|EPSD|PSP | HSF1 HSTF1 | LVQSNRILGVKRKIPLMLNDsGsAHSMPKYSRQFsLEHVHG |
| Q00613 | S419 | GPS6|PSP | HSF1 HSTF1 | QTMLSSHGFSVDTSALLDLFsPSVTVPDMSLPDLDSSLASI |
| Q00839 | S59 | EPSD|PSP | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q00987 | S260 | SIGNOR|EPSD|PSP | MDM2 | sVsDQFsVEFEVEsLDsEDYsLsEEGQELsDEDDEVyQVtV |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01518 | S338 | Sugiyama | CAP1 CAP | EPAVLELEGKKWRVENQENVsNLVIEDTELKQVAYIYKCVN |
| Q01538 | S429 | EPSD | MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1 | GLGEPGKAAKPLDTVRKSYYsKDPSRAEKREIKCPTPGCDG |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02750 | S218 | EPSD|PSP | MAP2K1 MEK1 PRKMK1 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGT |
| Q02750 | S222 | EPSD|PSP | MAP2K1 MEK1 PRKMK1 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGTHYSV |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06609 | S14 | EPSD|PSP | RAD51 RAD51A RECA | _______MAMQMQLEANADtsVEEESFGPQPISRLEQCGIN |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07817 | S62 | EPSD|PSP | BCL2L1 BCL2L BCLX | ESEMEtPsAINGNPSWHLADsPAVNGATGHSSSLDAREVIP |
| Q08050 | S730 | GPS6|SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | sGLAANRsLtEGLVLDtMNDsLsKILLDIsFPGLDEDPLGP |
| Q08050 | S739 | GPS6|SIGNOR|EPSD|PSP | FOXM1 FKHL16 HFH11 MPP2 WIN | tEGLVLDtMNDsLsKILLDIsFPGLDEDPLGPDNINWSQFI |
| Q08211 | S625 | Sugiyama | DHX9 DDX9 LKP NDH2 | DANCNLICGDEyGPETRLsMsQLNEKETPFELIEALLKYIE |
| Q08J23 | T755 | Sugiyama | NSUN2 SAKI TRM4 | GQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR________ |
| Q12834 | S170 | SIGNOR|PSP | CDC20 | VLYsQKAtPGSsRKTCRYIPsLPDRILDAPEIRNDYYLNLV |
| Q12888 | S1618 | SIGNOR|EPSD|PSP | TP53BP1 | EQYGLGPYEAVtPLtKAADIsLDNLVEGKRKRRsNVssPAt |
| Q13042 | S112 | EPSD|PSP | CDC16 ANAPC6 | VLDMEEPINKRLFEKYLKDEsGFKDPSSDWEMSQSSIKSSI |
| Q13127 | S1030 | PSP | REST NRSF XBR | GIHSHEGSDLSDNMsEGsDDsGLHGARPVPQESSRKNAKEA |
| Q13158 | S194 | SIGNOR|EPSD|PSP | FADD MORT1 GIG3 | ADLVQEVQQARDLQNRsGAMsPMsWNsDAsTSEAS______ |
| Q13188 | S15 | SIGNOR|PSP | STK3 KRS1 MST2 | ______MEQPPAPKSKLKKLsEDsLtKQPEEVFDVLEKLGE |
| Q13188 | S18 | PSP | STK3 KRS1 MST2 | ___MEQPPAPKSKLKKLsEDsLtKQPEEVFDVLEKLGEGsY |
| Q13188 | S316 | PSP | STK3 KRS1 MST2 | EIKAKRHEEQQRELEEEEENsDEDELDsHtMVKTSVESVGt |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13416 | S188 | EPSD|PSP | ORC2 ORC2L | KRLIVPRSHSDSESEYSASNsEDDEGVAQEHEEDTNAVIFS |
| Q13485 | T197 | SIGNOR|PSP | SMAD4 DPC4 MADH4 | HSIQTIQHPPSNRASTETyStPALLAPSESNATSTANFPNI |
| Q13526 | S65 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PIN1 | GKNGQGEPARVRCSHLLVKHsQSRRPsSWRQEKITRTKEEA |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q14151 | S194 | Sugiyama | SAFB2 KIAA0138 | PAQPPEHAVDGEGFKNtLEtssLNFKVtPDIEEsLLEPENE |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14203 | S179 | SIGNOR|EPSD|PSP | DCTN1 | GVAGASSSLGPSGSASAGELsSSEPSTPAQTPLAAPIIPTP |
| Q14204 | T1307 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FGRLKDDREKCAKAKEALELtDtGLLsGSEERVQVALEELQ |
| Q14247 | T328 | Sugiyama | CTTN EMS1 | GKyGVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKts |
| Q14257 | S146 | Sugiyama | RCN2 ERC55 | MyDRVIDFDENtALDDAEEEsFRKLHLKDKKRFEKANQDSG |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14674 | S1399 | SIGNOR|EPSD|PSP | ESPL1 ESP1 KIAA0165 | QAPRVQQRVQTRLKVNFsDDsDLEDPVSAEAWLAEEPKRRG |
| Q14674 | T1363 | SIGNOR|EPSD|PSP | ESPL1 ESP1 KIAA0165 | LPCtPKPPDRIRQAGPHVPFtVFEEVCPTESKPEVPQAPRV |
| Q14676 | S20 | PSP | MDC1 KIAA0170 NFBD1 | _MEDtQAIDWDVEEEEETEQsSESLRCNVEPVGRLHIFSGA |
| Q14676 | T4 | PSP | MDC1 KIAA0170 NFBD1 | _________________MEDtQAIDWDVEEEEETEQsSESL |
| Q14676 | T847 | PSP | MDC1 KIAA0170 NFBD1 | ERGPLERETEKLLPERQTDVtGEEELTKGKQDREQKQLLAR |
| Q14677 | S164 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | RLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKW |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14677 | T215 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | FPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPERCsDsD |
| Q14697 | S913 | Sugiyama | GANAB G2AN KIAA0088 | VIIGAGKPAAVVLQTKGSPEsRLsFQHDPEtsVLVLRKPGI |
| Q14697 | T923 | Sugiyama | GANAB G2AN KIAA0088 | VVLQTKGSPEsRLsFQHDPEtsVLVLRKPGINVASDWSIHL |
| Q14790 | S305 | SIGNOR|PSP | CASP8 MCH5 | DDCTVEQIYEILKIYQLMDHsNMDCFICCILSHGDKGIIYG |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15013 | S102 | GPS6|SIGNOR|PSP | MAD2L1BP CMT2 KIAA0110 | YQRQQLPLPYEQLKHFYRKPsPQAEEMLKKKPRATTEVSSR |
| Q15013 | S246 | GPS6 | MAD2L1BP CMT2 KIAA0110 | FRPKLNYRVPSRGHKLTVTLsCGRPSIRTTAWEDYIWFQAP |
| Q15022 | S539 | SIGNOR|EPSD|PSP | SUZ12 CHET9 JJAZ1 KIAA0160 | PVKRTPITHILVCRPKRTKAsMsEFLEsEDGEVEQQRTYSS |
| Q15022 | S541 | SIGNOR|EPSD|PSP | SUZ12 CHET9 JJAZ1 KIAA0160 | KRTPITHILVCRPKRTKAsMsEFLEsEDGEVEQQRTYSSGH |
| Q15022 | S546 | SIGNOR|EPSD|PSP | SUZ12 CHET9 JJAZ1 KIAA0160 | THILVCRPKRTKAsMsEFLEsEDGEVEQQRTYSSGHNRLYF |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15208 | T183 | SIGNOR|PSP | STK38 NDR1 | YLIMEFLPGGDMMTLLMKKDtLTEEETQFYIAETVLAIDSI |
| Q15208 | T407 | SIGNOR|PSP | STK38 NDR1 | WEHIRERPAAIsIEIKSIDDtSNFDEFPESDILKPTVATSN |
| Q15208 | T7 | SIGNOR|PSP | STK38 NDR1 | ______________MAMTGstPCssMSNHTKERVTMTKVTL |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15398 | S777 | Sugiyama | DLGAP5 DLG7 KIAA0008 | sItSQDVLMssPEKNTAsQNsILEEGEtKIsQsELFDNKsL |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15435 | S24 | EPSD|PSP | PPP1R7 SDS22 | ERGAGQQQsQEMMEVDRRVEsEEsGDEEGKKHssGIVADLs |
| Q15435 | S27 | EPSD|PSP | PPP1R7 SDS22 | AGQQQsQEMMEVDRRVEsEEsGDEEGKKHssGIVADLsEQs |
| Q15435 | S44 | EPSD|PSP | PPP1R7 SDS22 | sEEsGDEEGKKHssGIVADLsEQsLKDGEERGEEDPEEEHE |
| Q15435 | S47 | EPSD|PSP | PPP1R7 SDS22 | sGDEEGKKHssGIVADLsEQsLKDGEERGEEDPEEEHELPV |
| Q15435 | T277 | EPSD|PSP | PPP1R7 SDS22 | LYLSHNGIEVIEGLENNNKLtMLDIASNRIKKIENISHLTE |
| Q15468 | S1108 | EPSD|PSP | STIL SIL | NNCDPFSLLHINTDRSTVGLsLIsPNNMsFATKKYMKRYGL |
| Q15468 | S1116 | EPSD|PSP | STIL SIL | LHINTDRSTVGLsLIsPNNMsFATKKYMKRYGLLQssDNsE |
| Q15545 | S200 | Sugiyama | TAF7 TAF2F TAFII55 | RWEIIAEDETKEAENQGLDIssPGMsGHRQGHDsLEHDELR |
| Q15785 | S51 | Sugiyama | TOMM34 URCC3 | LyGRALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCI |
| Q16143 | S118 | SIGNOR|EPSD|PSP | SNCB | VAQEAAEEPLIEPLMEPEGEsYEDPPQEEyQEYEPEA____ |
| Q16513 | S590 | Sugiyama | PKN2 PRK2 PRKCL2 | LEPEPPPAPPRAssLGEIDEssELRVLDIPGQDsEtVFDIQ |
| Q16531 | T1125 | Sugiyama | DDB1 XAP1 | MQEVVANLQYDDGSGMKREAtADDLIKVVEELtRIH_____ |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q17RH5 | S1010 | PSP | RAPGEF2 | PATNTLPKNPGDKKPVKSETsPVAPRAGSQQKAQSLPQPQQ |
| Q17RH5 | S1164 | PSP | RAPGEF2 | SNSSFDSVPVSLHDERRQRHsVSIVETNLGMGRMERRTMIE |
| Q17RH5 | S794 | PSP | RAPGEF2 | KIIKHFIKIALHCRECKNFNsMFAIISGLNLAPVARLRTTW |
| Q17RH5 | S921 | PSP | RAPGEF2 | VNMDPALMFRTRKKKWRSLGsLSQGSTNATVLDVAQTGGHK |
| Q17RH5 | T632 | PSP | RAPGEF2 | ISKDTTAKEVVIQAIREFAVtATPDQYSLCEVSVTPEGVIK |
| Q27J81 | S1202 | Sugiyama | INF2 C14orf151 C14orf173 | EsALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRR |
| Q27J81 | T1039 | Sugiyama | INF2 C14orf151 C14orf173 | PAGDPVGSTRCPASEPGLDAtTASESRGWDLVDAVtPGPQP |
| Q2M2Z5 | T379 | GPS6|SIGNOR|EPSD|PSP | KIZ C20orf19 NCRNA00153 PLK1S1 HT013 | KPFRKMQEEEEESWSTSSDLtISISEDDLILESPEPQPNPG |
| Q2NKX8 | T1063 | GPS6|EPSD|PSP | ERCC6L PICH | INPFNTSLFQFSsVKQFDAStPKNDIsPPGRFFssQIPssV |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q38SD2 | S1817 | SIGNOR|EPSD|PSP | LRRK1 KIAA1790 | PAASHTANPKVPEGDSIADVsIMYSEELGTQILIHQESLTD |
| Q3KR16 | T574 | SIGNOR|EPSD|PSP | PLEKHG6 | AEGRTPEFSTIIPHLVVTEDtDEDAPLVPDDTSDSGYGTLI |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q49MG5 | S289 | GPS6|SIGNOR|EPSD|PSP | MAP9 ASAP | PNEEITENHNSLKSDENKENsFSADHVTTAVEKSKEsQVTA |
| Q53EZ4 | S436 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | CEP55 C10orf3 URCC6 | TENREKVAAsPKsPtAALNEsLVECPKCNIQYPATEHRDLL |
| Q53GL7 | T601 | SIGNOR|PSP | PARP10 | DSTGGDQEDVSLEEVRELLAtLEGLDLDGEDWLPRELEEEG |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | S63 | Sugiyama | HSP90AB3P HSP90BC | LISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERT |
| Q58FF7 | S67 | Sugiyama | HSP90AB3P HSP90BC | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERTLALV |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S63 | Sugiyama | HSP90AB2P HSP90BB | LISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHT |
| Q58FF8 | S67 | Sugiyama | HSP90AB2P HSP90BB | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHTLTLV |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5H9R7 | S868 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | RPPsssPEQRTGQPSAPGDtsVNGPV_______________ |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q5T3I0 | S272 | Sugiyama | GPATCH4 GPATC4 | VsDEREGTTKGNEKEDAAGtsGLGELNSREQtNQSLRKGKK |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6IBW4 | S288 | EPSD|PSP | NCAPH2 CAPH2 | PEASAPKAALEPKEsRsPQQsAALPRRYMLREREGAPEPAs |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PGQ7 | S497 | SIGNOR|EPSD|PSP | BORA C13orf34 | MSPLAESSVIPCESSNIQMDsGYNtQNCGSNIMDTVGAESY |
| Q6PGQ7 | T501 | SIGNOR|EPSD|PSP | BORA C13orf34 | AESSVIPCESSNIQMDsGYNtQNCGSNIMDTVGAESYCKES |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q6UXH1 | T300 | Sugiyama | CRELD2 UNQ185/PRO211 | GYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSYVCVCP |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71F23 | S77 | SIGNOR|EPSD|PSP | CENPU ICEN24 KLIP1 MLF1IP PBIP1 | RLGENEKDEETYETFDPPLHstAIYADEEEFSKHCGLsLss |
| Q71F23 | T78 | GPS6|SIGNOR|EPSD|PSP | CENPU ICEN24 KLIP1 MLF1IP PBIP1 | LGENEKDEETYETFDPPLHstAIYADEEEFSKHCGLsLsst |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q76N32 | S332 | SIGNOR|PSP | CEP68 KIAA0582 | GPQLPKHLDSRVPADPVLQDsGVDLDSFSVSPASTLKsPtN |
| Q7L2Z9 | S138 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | LQQCEtLKVPPKKMEDLtNVssLLNMERARDKANEEGLALL |
| Q7L2Z9 | S139 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | QQCEtLKVPPKKMEDLtNVssLLNMERARDKANEEGLALLQ |
| Q7L2Z9 | S248 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | ILALIPNQNALLKDLDILHNssQMKsMstFIEEAYKKLDAS |
| Q7L2Z9 | S249 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | LALIPNQNALLKDLDILHNssQMKsMstFIEEAYKKLDAS_ |
| Q7L2Z9 | S253 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | PNQNALLKDLDILHNssQMKsMstFIEEAYKKLDAS_____ |
| Q7L2Z9 | S255 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | QNALLKDLDILHNssQMKsMstFIEEAYKKLDAS_______ |
| Q7L2Z9 | T123 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | KEEIQYHLNFLKKRLLQQCEtLKVPPKKMEDLtNVssLLNM |
| Q7L2Z9 | T135 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | KRLLQQCEtLKVPPKKMEDLtNVssLLNMERARDKANEEGL |
| Q7L2Z9 | T256 | SIGNOR|EPSD|PSP | CENPQ C6orf139 | NALLKDLDILHNssQMKsMstFIEEAYKKLDAS________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z2W4 | S492 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | VQATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEI |
| Q7Z3K3 | S28 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | MECEEEELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQP |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86VS8 | S230 | Sugiyama | HOOK3 | QEEKSSLLAENQVLMERLNQsDsIEDPNsPAGRRHLQLQTQ |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IUD2 | S824 | Sugiyama | ERC1 ELKS KIAA1081 RAB6IP2 | KKKsAQMLEEARRREDNLNDsSQQLQDSLRKKDDRIEELEE |
| Q8IWB6 | S437 | SIGNOR|EPSD|PSP | TEX14 SGK307 | TQLYNWAAPEVILQKAATVKsDIYSFSMIMQEILTDDIPWK |
| Q8IYE1 | S680 | Sugiyama | CCDC13 | LTTRLAIQVEENEMLKAALGsALRGKEEDFRMYHEILGQVK |
| Q8IZD2 | S861 | EPSD|PSP | KMT2E MLL5 | ERsRsPAVNGENKsPLLLNDsCSLPDLTTPLKKRRFYQLLD |
| Q8N1F7 | S72 | Sugiyama | NUP93 KIAA0095 | sQETADVKASVLLGsRGLDIsHIsQRLEsLsAAtTFEPLEP |
| Q8N4N8 | S200 | PSP | KIF2B | TRNPNYEIMHMIEEYRRHLDssKIsVLEPPQEHRICVCVRK |
| Q8N4N8 | S201 | PSP | KIF2B | RNPNYEIMHMIEEYRRHLDssKIsVLEPPQEHRICVCVRKR |
| Q8N4N8 | S204 | SIGNOR|EPSD|PSP | KIF2B | NYEIMHMIEEYRRHLDssKIsVLEPPQEHRICVCVRKRPLN |
| Q8N4N8 | T125 | SIGNOR|EPSD|PSP | KIF2B | AIRDQRTATKWVAMIPQKNQtASGDSLDVRVPSKPCLMKQK |
| Q8N684 | S166 | Sugiyama | CPSF7 | PGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVPRGGIP |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NHV4 | S397 | GPS6|SIGNOR|EPSD|PSP | NEDD1 | sINTDtLSKEtDsGKNQDFssFDDtGKssLGDMFsPIRDDA |
| Q8NHV4 | S426 | GPS6|SIGNOR|EPSD|PSP | NEDD1 | LGDMFsPIRDDAVVNKGsDEsIGKGDGFDFLPQLNSVFPPR |
| Q8NHV4 | S637 | GPS6|SIGNOR|EPSD|PSP | NEDD1 | EMIKQFHMQLNEMHSLLERYsVNEGLVAEIERLREENKRLR |
| Q8NHV4 | T382 | GPS6|SIGNOR|EPSD|PSP | NEDD1 | GKGTVAVQEKAGLPRsINTDtLSKEtDsGKNQDFssFDDtG |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TCG1 | S904 | EPSD|PSP | CIP2A KIAA1524 | MIAMIHSLSGGKINPETVNLsI___________________ |
| Q8TD19 | T210 | SIGNOR|PSP | NEK9 KIAA1995 NEK8 NERCC | IKLGDYGLAKKLNSEYSMAEtLVGtPYYMSPELCQGVKYNF |
| Q8TEP8 | T44 | SIGNOR|PSP | CEP192 KIAA1569 PP8407 | SGILENVTLSSNLGLPVAVStLARDRSSTDNRYPDIQASYL |
| Q8WU90 | T345 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DsVsVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDEN |
| Q8WVJ2 | S153 | Sugiyama | NUDCD2 | GFDFsGAEIsGNytKGGPDFsNLEK________________ |
| Q92574 | S468 | EPSD|PSP | TSC1 KIAA0243 TSC | PGSKGSVTLSDLPGFLGDLAsEEDsIEKDKEEAAIsRELsE |
| Q92574 | S579 | EPSD|PSP | TSC1 KIAA0243 TSC | CGSADESPAGDRECQTSLETsIFTPsPCKIPPPTRVGFGsG |
| Q92598 | T795 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | DQDPVVRAQEIKTKIKELNNtCEPVVTQPKPKIEsPKLERt |
| Q92994 | S450 | EPSD|PSP | BRF1 BRF GTF3B TAF3B2 TAF3C | CIssQssDPKDAsGDGELDLsGIDDLEIDRYILNESEARVK |
| Q92994 | T270 | PSP | BRF1 BRF GTF3B TAF3B2 TAF3C | ISVVKVCESTLRKRLTEFEDtPTSQLTIDEFMKIDLEEECD |
| Q96A49 | S313 | Sugiyama | SYAP1 PRO3113 | EMEQLVLDKKQEEtAVLEEDsADWEKELQQELQEyEVVtES |
| Q96A49 | T306 | Sugiyama | SYAP1 PRO3113 | NQEDLRKEMEQLVLDKKQEEtAVLEEDsADWEKELQQELQE |
| Q96AC1 | S666 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | VHEFIGGYIFLSTRAKDQNEsLDEEMFyKLTSGWV______ |
| Q96BK5 | S110 | SIGNOR|EPSD|PSP | PINX1 LPTL LPTS | ELNTCHGQETTDSSDKKEKKsFSLEEKsKISKNRVHYMKFT |
| Q96BK5 | S117 | SIGNOR|EPSD|PSP | PINX1 LPTL LPTS | QETTDSSDKKEKKsFSLEEKsKISKNRVHYMKFTKGKDLSS |
| Q96BK5 | S226 | SIGNOR|EPSD|PSP | PINX1 LPTL LPTS | QVERKRGKKRNKEATGKDVEsyLQPKAKRHTEGKPERAEAQ |
| Q96BK5 | T141 | SIGNOR|EPSD|PSP | PINX1 LPTL LPTS | KNRVHYMKFTKGKDLSSRSKtDLDCIFGKRQSKKtPEGDAs |
| Q96BK5 | T317 | SIGNOR|EPSD|PSP | PINX1 LPTL LPTS | RGKKKLQKPVEIAEDATLEEtLVKKKKKKDSK_________ |
| Q96BM9 | S150 | Sugiyama | ARL8A ARL10B GIE2 | NKRDLPGALDEKELIEKMNLsAIQDREICCYSISCKEKDNI |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96CV9 | S177 | SIGNOR|EPSD|PSP|Sugiyama | OPTN FIP2 GLC1E HIP7 HYPL NRP | LLGIVSELQLKLNssGssEDsFVEIRMAEGEAEGsVKEIKH |
| Q96FC3 | S204 | GPS6 | TPX2 | IRKYQGLEIKSSDQPLTVPVsPKFSTRFHC___________ |
| Q96FF9 | T115 | PSP | CDCA5 | RELTKEDLFKtHsVPAtPtstPVPNPEAEsssKEGELDARD |
| Q96FF9 | T151 | SIGNOR|PSP | CDCA5 | LDARDLEMsKKVRRsYsRLEtLGsAststPGRRsCFGFEGL |
| Q96GD4 | T236 | PSP | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | IADFGWSVHAPsLRRKtMCGtLDYLPPEMIEGRMHNEKVDL |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96T23 | S1359 | SIGNOR|EPSD|PSP | RSF1 HBXAP XAP8 | KPyRIEsDEEEDFENVGKVGsPLDysLVDLPstNGQsPGKA |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99615 | S94 | Sugiyama | DNAJC7 TPR2 TTC2 | MLGRFREALGDAQQsVRLDDsFVRGHLREGKCHLSLGNAMA |
| Q99640 | S426 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PKMYT1 MYT1 | PLGPPAtPPGsPPCSLLLDSsLSSNWDDDSLGPSLsPEAVL |
| Q99640 | T495 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PKMYT1 MYT1 | PPRGsFPsFEPRNLLSLFEDtLDPT________________ |
| Q99661 | S621 | SIGNOR|PSP | KIF2C KNSL6 | QMETEEMEACSNGALIPGNLsKEEEELssQMssFNEAMTQI |
| Q99661 | S632 | SIGNOR|PSP | KIF2C KNSL6 | NGALIPGNLsKEEEELssQMssFNEAMTQIRELEEKAMEEL |
| Q99661 | S633 | SIGNOR|PSP | KIF2C KNSL6 | GALIPGNLsKEEEELssQMssFNEAMTQIRELEEKAMEELK |
| Q99661 | S715 | SIGNOR|EPSD|PSP | KIF2C KNSL6 | SALRDVIKALRLAMQLEEQAsRQISSKKRPQ__________ |
| Q99708 | S723 | PSP | RBBP8 CTIP | MKKQEQKGEKSSNEERKMNDsLEDMFDRtTHEEYESCLADS |
| Q99708 | T693 | PSP | RBBP8 CTIP | IDTKDGSQSKLGGETVDMDCtLVSETVLLKMKKQEQKGEKS |
| Q99708 | T731 | PSP | RBBP8 CTIP | EKSSNEERKMNDsLEDMFDRtTHEEYESCLADSFsQAADEE |
| Q99741 | T37 | SIGNOR|EPSD|PSP | CDC6 CDC18L | RKLSRALNKAKNSSDAKLEPtNVQTVtCsPRVKALPLsPRK |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQQ3 | S189 | EPSD|PSP | GORASP1 GOLPH5 GRASP65 | KSDSCREVTVTPNAAWGGEGsLGCGIGYGYLHRIPTQPPSY |
| Q9BRS2 | T128 | Sugiyama | RIOK1 RIO1 | PADKVLRKFENKINLDKLNVtDsVINKVTEKSRQKEADMYR |
| Q9BVS4 | S335 | SIGNOR|EPSD|PSP|Sugiyama | RIOK2 RIO2 | LLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsENEsE |
| Q9BVS4 | S380 | SIGNOR|EPSD|PSP | RIOK2 RIO2 | EEsEGCYCRssGDPEQIKEDsLsEEsADARsFEMTEFNQAL |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BVS4 | S548 | SIGNOR|EPSD|PSP | RIOK2 RIO2 | IFTKQRRENMQNIKssLEAAsFWGE________________ |
| Q9BXJ9 | S855 | Sugiyama | NAA15 GA19 NARG1 NATH TBDN100 | ALAFMPPGYEEDMKItVNGDssAEAEELANEI_________ |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9C0C2 | S1046 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GLFsPstAHVPDGALGQRDQssWQNsDAsQEVGGHQERQQA |
| Q9C0C2 | S1173 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KttAGsVDWTDQLGLRNLEVssCVGsGGssEAREsAVGQMG |
| Q9C0C2 | S1371 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QNVELFGAPSEAREHGVGGVsQCPEPGLRHNGsLsPGLEAR |
| Q9C0C2 | S936 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GRyssQDADEQDWEFQKRDVsLGTyGSRAAEPQEQEFGKSA |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9H0D6 | S499 | Sugiyama | XRN2 | sFtsDGsPsPLGGIKRKAEDsDsEPEPEDNVRLWEAGWKQR |
| Q9H0H5 | S149 | GPS6|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | NRGQPSSSNAGNKRLstIDEsGsILsDIsFDKtDEsLDWDs |
| Q9H0H5 | S157 | GPS6|SIGNOR|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | NAGNKRLstIDEsGsILsDIsFDKtDEsLDWDssLVKTFKL |
| Q9H0H5 | S164 | GPS6|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | stIDEsGsILsDIsFDKtDEsLDWDssLVKTFKLKKREKRR |
| Q9H0H5 | S170 | GPS6|SIGNOR|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | GsILsDIsFDKtDEsLDWDssLVKTFKLKKREKRRstsRQF |
| Q9H0H5 | S214 | SIGNOR|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | PPGPVKKtRsIGsAVDQGNEsIVAKTTVTVPNDGGPIEAVS |
| Q9H0H5 | T260 | SIGNOR|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | PYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGtPQs |
| Q9H1A4 | S355 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | PsLHsRsPsISNMAALsRAHsPALGVHsFsGVQRFNIssHN |
| Q9H1A4 | S373 | EPSD|PSP | ANAPC1 TSG24 | AHsPALGVHsFsGVQRFNIssHNQsPKRHSISHSPNSNSNG |
| Q9H1A4 | S377 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | ALGVHsFsGVQRFNIssHNQsPKRHSISHSPNSNSNGSFLA |
| Q9H1A4 | S547 | EPSD|PSP | ANAPC1 TSG24 | RPstPLDGVstPKPLSKLLGsLDEVVLLsPVPELRDssKLH |
| Q9H1A4 | S686 | GPS6|ELM|iPTMNet|EPSD | ANAPC1 TSG24 | NMMGYNTDRLAWTRNFDFEGsLsPVIAPKKARPsEtGsDDD |
| Q9H1A4 | S688 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | MGYNTDRLAWTRNFDFEGsLsPVIAPKKARPsEtGsDDDWE |
| Q9H1A4 | T291 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | LRRVKSEEENVVLKFsEQGGtPQNVAtsssLTAHLRsLsKG |
| Q9H1A4 | T520 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | YTGVVRVGKVFIPGLPAPsLtMsNtMPRPstPLDGVstPKP |
| Q9H1A4 | T530 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC1 TSG24 | FIPGLPAPsLtMsNtMPRPstPLDGVstPKPLSKLLGsLDE |
| Q9H1A4 | T701 | EPSD|PSP | ANAPC1 TSG24 | FDFEGsLsPVIAPKKARPsEtGsDDDWEYLLNSDYHQNVES |
| Q9H2D6 | T2229 | SIGNOR | TRIOBP KIAA1662 TARA HRIHFB2122 | YSQKCLEIGALMRQAEEREHtLRRCQQEGQELLRHNQELHG |
| Q9H2D6 | T447 | SIGNOR | TRIOBP KIAA1662 TARA HRIHFB2122 | NPRTSCAQRDNPRASSPSRAtRDNPTTSCAQRDNPRASRTS |
| Q9H2G2 | S344 | Sugiyama | SLK KIAA0204 STK2 | EEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVS |
| Q9H6R7 | S686 | SIGNOR|PSP | WDCP C2orf44 PP384 | ATQEIIIRDGSLSRSDVFRDsFsHsPGAVsSLKVFTGLAAP |
| Q9H6R7 | S695 | SIGNOR|PSP | WDCP C2orf44 PP384 | GSLSRSDVFRDsFsHsPGAVsSLKVFTGLAAPSLDTTGCCN |
| Q9HAW4 | S30 | SIGNOR|EPSD|PSP | CLSPN | HLEINDPNVISQEEADSPSDsGQGsYETIGPLSEGDSDEEI |
| Q9HBU6 | T109 | Sugiyama | ETNK1 EKI1 | AMANYIHVPPGSPEVPKLNVtVQDQEEHRCREGALSLLQHL |
| Q9NQ48 | S209 | Sugiyama | LZTFL1 | LQDLQLDQGNQKDFIKAQDLsNLENtVAALKSEFQKTLNDK |
| Q9NQ48 | T214 | Sugiyama | LZTFL1 | LDQGNQKDFIKAQDLsNLENtVAALKSEFQKTLNDKTENQK |
| Q9NQP4 | T16 | Sugiyama | PFDN4 PFD4 | _____MAATMKKAAAEDVNVtFEDQQKINKFARNTSRITEL |
| Q9NRF8 | S574 | Sugiyama | CTPS2 | YLQQGCKLsssDRysDAsDDsFSEPRIAELEIS________ |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NS56 | S718 | GPS6|SIGNOR|EPSD|PSP | TOPORS LUN TP53BPL | SRYKWEYTYYSRNKDRDGYEsSYRRRTLSRAHYSRQsssPE |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NSG2 | S43 | PSP | FIRRM APOLO1 C1orf112 | TVKLFDDMMYELTSQARGLssQNLEIQTTLRNILQTMVQLL |
| Q9NSG2 | S744 | PSP | FIRRM APOLO1 C1orf112 | NHEEIVPQCLSSEETKNKVVsFLEKTGFVDETEAAKVERVK |
| Q9NVJ2 | S150 | Sugiyama | ARL8B ARL10C GIE1 | NKRDLPNALDEKQLIEKMNLsAIQDREICCYSISCKEKDNI |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9NYZ3 | S223 | EPSD | GTSE1 | PGPPHSAHALPRESCTAHAAsQAATQRKPGTKLLLPRAASV |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9UBB4 | S77 | SIGNOR|EPSD|PSP | ATXN10 SCA10 | SSHAVELACRDPSQVENLASsLQLItECFRCLRNACIECSV |
| Q9UBB4 | T82 | SIGNOR|EPSD|PSP | ATXN10 SCA10 | ELACRDPSQVENLASsLQLItECFRCLRNACIECSVNQNSI |
| Q9UBW7 | S303 | SIGNOR|EPSD|PSP | ZMYM2 FIM RAMP ZNF198 | DSWISQSASFPRNQKQPGVDsLsPVAsLPKQIFQPSVQQQP |
| Q9UBW7 | S305 | SIGNOR|EPSD|PSP | ZMYM2 FIM RAMP ZNF198 | WISQSASFPRNQKQPGVDsLsPVAsLPKQIFQPSVQQQPTK |
| Q9UBW7 | S309 | SIGNOR|EPSD|PSP | ZMYM2 FIM RAMP ZNF198 | SASFPRNQKQPGVDsLsPVAsLPKQIFQPSVQQQPTKPVKV |
| Q9UJX2 | T562 | GPS6|EPSD|PSP | CDC23 ANAPC8 | tREEGKALLRQILQLRNQGEtPttEVPAPFFLPAsLsANNt |
| Q9UJX2 | T565 | EPSD|PSP | CDC23 ANAPC8 | EGKALLRQILQLRNQGEtPttEVPAPFFLPAsLsANNtPtR |
| Q9UJX3 | S17 | ELM|PSP | ANAPC7 APC7 | ____MNVIDHVRDMAAAGLHsNVRLLsSLLLTMsNNNPELF |
| Q9UJX3 | S23 | ELM|PSP | ANAPC7 APC7 | VIDHVRDMAAAGLHsNVRLLsSLLLTMsNNNPELFSPPQKY |
| Q9UJX3 | S30 | ELM|PSP | ANAPC7 APC7 | MAAAGLHsNVRLLsSLLLTMsNNNPELFSPPQKYQLLVYHA |
| Q9UJX3 | S64 | GPS6|EPSD | ANAPC7 APC7 | QLLVYHADSLFHDKEYRNAVsKYTMALQQKKALSKTSKVRP |
| Q9UJX5 | S779 | GPS6|ELM|iPTMNet|EPSD|PSP | ANAPC4 APC4 | DEEEEASNKPVKIKEEVLsEsEAENQQAGAAALAPEIVIKV |
| Q9UK45 | S16 | Sugiyama | LSM7 | _____MADKEKKKKEsILDLsKYIDKTIRVKFQGGREASGI |
| Q9UKT4 | S145 | EPSD|PSP | FBXO5 EMI1 FBX5 | QTLNSTNEIEALETSRLyEDsGYSsFSLQSGLSEHEEGSLL |
| Q9UKT4 | S149 | EPSD|PSP | FBXO5 EMI1 FBX5 | STNEIEALETSRLyEDsGYSsFSLQSGLSEHEEGSLLEENF |
| Q9UNF0 | S273 | Sugiyama | PACSIN2 | KHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFRANHGPG |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQE7 | S886 | Sugiyama | SMC3 BAM BMH CSPG6 SMC3L1 | LEAINKRVKDTMARSEDLDNsIDKTEAGIKELQKSMERWKN |
| Q9Y265 | S29 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | TTKTQRIAsHSHVKGLGLDEsGLAKQAASGLVGQENAREAC |
| Q9Y265 | T239 | EPSD|PSP | RUVBL1 INO80H NMP238 TIP49 TIP49A | EyVPLPKGDVHKKKEIIQDVtLHDLDVANARPQGGQDILSM |
| Q9Y266 | S274 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NUDC | WSRLVssDPEINtKKINPENsKLsDLDsEtRsMVEKMMYDQ |
| Q9Y266 | S326 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NUDC | EQKKQEILKKFMDQHPEMDFsKAKFN_______________ |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2I6 | S686 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NINL KIAA0980 NLP | RREVSVLEGQKADLEELHEKsQEVIWGLQEQLQDTARGPEP |
| Q9Y2I6 | S87 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NINL KIAA0980 NLP | KEGFVAVLSSNAGVRPSDEDssSLESAASSAIPPKYVNGSK |
| Q9Y2I6 | S88 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NINL KIAA0980 NLP | EGFVAVLSSNAGVRPSDEDssSLESAASSAIPPKYVNGSKW |
| Q9Y2I6 | T161 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NINL KIAA0980 NLP | WRSASLESVESPKSDEEAEStKEAQNELFEAQGQLQTWDSE |
| Q9Y2L5 | S377 | Sugiyama | TRAPPC8 KIAA1012 | FRGLLPHIEKTIRQLNDQLIsRKGLSRSLFSATKKWFSGSK |
| Q9Y2R5 | S128 | Sugiyama | MRPS17 RPMS17 HSPC011 | SPLSSETTQLSKNLEELNIssAQ__________________ |
| Q9Y2T1 | S311 | SIGNOR|EPSD|PSP | AXIN2 | FAPATSANDSEISSDALTDDsMSMTDSSVDGIPPYRVGSKK |
| Q9Y2Z0 | S331 | SIGNOR|EPSD|PSP | SUGT1 | RLFQQIysDGsDEVKRAMNKsFMESGGTVLSTNWSDVGKRK |
| Q9Y394 | S329 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | TNKMGKKRIENFKSGVDADssyFKIFKTKHD__________ |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5T5 | S330 | SIGNOR|EPSD|PSP | USP16 MSTP039 | GMRAEEHQRVSKGILKAFGNsTEKLDEELKNKVKDYEKKKS |
| Q9Y5T5 | S386 | SIGNOR|EPSD|PSP | USP16 MSTP039 | MIMCDQCRTVSLVHESFLDLsLPVLDDQSGKKSVNDKNLKK |
| Q9Y5T5 | S486 | SIGNOR|EPSD|PSP | USP16 MSTP039 | HLNDICTIDHPEDSEYEAEMsLQGEVNIKSNHISQEGVMHK |
| Q9Y6D9 | S22 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | EDLGENtMVLSTLRsLNNFIsQRVEGGsGLDISTSAPGSLQ |
| Q9Y6D9 | S29 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | MVLSTLRsLNNFIsQRVEGGsGLDISTSAPGSLQMQYQQSM |
| Q9Y6D9 | T680 | SIGNOR|EPSD|PSP | MAD1L1 MAD1 TXBP181 | GDCLIFKATSPSGSKMQLLEtEFSHTVGELIEVHLRRQDsI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.345590e-13 | 12.871 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.831901e-11 | 10.737 | 1 | 1 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.709483e-10 | 9.767 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.255827e-09 | 8.901 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.205833e-09 | 8.284 | 1 | 1 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.055964e-08 | 7.687 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.945470e-08 | 7.048 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.778982e-07 | 6.750 | 1 | 1 |
| Mitotic Anaphase | R-HSA-68882 | 1.790369e-07 | 6.747 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.077256e-07 | 6.683 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.615742e-07 | 6.582 | 1 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.897477e-07 | 6.310 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.362831e-07 | 6.196 | 1 | 1 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.312987e-07 | 6.136 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.312987e-07 | 6.136 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.521187e-07 | 6.069 | 1 | 1 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.521187e-07 | 6.069 | 1 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.471363e-07 | 6.072 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.026865e-06 | 5.693 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.457806e-06 | 5.609 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.468780e-06 | 5.189 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.727963e-06 | 5.172 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.399914e-05 | 4.620 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.594289e-05 | 4.586 | 1 | 1 |
| Signaling by Hippo | R-HSA-2028269 | 2.947966e-05 | 4.530 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.658732e-05 | 4.437 | 1 | 1 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.172649e-05 | 4.286 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.247307e-05 | 4.280 | 1 | 1 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.366843e-05 | 4.270 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.517532e-05 | 4.258 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.274723e-05 | 4.202 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.988744e-05 | 4.156 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.988744e-05 | 4.156 | 1 | 1 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.796857e-05 | 4.168 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.932989e-05 | 4.159 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.648831e-05 | 4.063 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.641594e-05 | 4.016 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.246395e-04 | 3.904 | 1 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.336127e-04 | 3.874 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.343414e-04 | 3.872 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.402882e-04 | 3.853 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.860125e-04 | 3.730 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.860125e-04 | 3.730 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.860125e-04 | 3.730 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.860125e-04 | 3.730 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.940696e-04 | 3.712 | 1 | 1 |
| G2/M Transition | R-HSA-69275 | 2.176557e-04 | 3.662 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.337887e-04 | 3.631 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.450172e-04 | 3.611 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.601887e-04 | 3.585 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.698283e-04 | 3.569 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.711367e-04 | 3.567 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.902403e-04 | 3.537 | 1 | 1 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.929122e-04 | 3.533 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.816693e-04 | 3.418 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.866683e-04 | 3.413 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.866683e-04 | 3.413 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.866683e-04 | 3.413 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.866683e-04 | 3.413 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.170449e-04 | 3.380 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.280036e-04 | 3.369 | 1 | 1 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.304198e-04 | 3.366 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.562314e-04 | 3.341 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.143275e-04 | 3.289 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.637960e-04 | 3.249 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.765507e-04 | 3.239 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.789278e-04 | 3.237 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.069858e-04 | 3.217 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.137861e-04 | 3.146 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.503391e-04 | 3.125 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.371040e-04 | 3.132 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.549017e-04 | 3.122 | 1 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.829487e-04 | 3.106 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.829487e-04 | 3.106 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.840779e-04 | 3.054 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.213796e-04 | 3.036 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.975045e-04 | 3.001 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.022161e-03 | 2.990 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.024440e-03 | 2.990 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.006432e-03 | 2.997 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.024851e-03 | 2.989 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.049211e-03 | 2.979 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.075001e-03 | 2.969 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.178847e-03 | 2.929 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.158489e-03 | 2.936 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.224734e-03 | 2.912 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.339115e-03 | 2.873 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.468838e-03 | 2.833 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.509938e-03 | 2.821 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.540345e-03 | 2.812 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.653597e-03 | 2.782 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.658067e-03 | 2.780 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.718021e-03 | 2.765 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.816592e-03 | 2.741 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.974384e-03 | 2.705 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.164971e-03 | 2.665 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.117309e-03 | 2.674 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.163725e-03 | 2.665 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.123899e-03 | 2.673 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.164971e-03 | 2.665 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.240165e-03 | 2.650 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.254065e-03 | 2.647 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.263581e-03 | 2.645 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.337849e-03 | 2.631 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.349053e-03 | 2.629 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.445264e-03 | 2.612 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.423116e-03 | 2.616 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.452450e-03 | 2.610 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.452450e-03 | 2.610 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.600992e-03 | 2.585 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.652507e-03 | 2.576 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.855584e-03 | 2.544 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.951141e-03 | 2.530 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.279090e-03 | 2.484 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.315060e-03 | 2.480 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.279079e-03 | 2.484 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.667246e-03 | 2.436 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.856669e-03 | 2.414 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.878095e-03 | 2.411 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.996093e-03 | 2.398 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.174549e-03 | 2.379 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.174549e-03 | 2.379 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.174549e-03 | 2.379 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.443741e-03 | 2.352 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.443741e-03 | 2.352 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.718772e-03 | 2.326 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.414327e-03 | 2.355 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.512242e-03 | 2.346 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.873312e-03 | 2.312 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.873312e-03 | 2.312 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.931798e-03 | 2.307 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.182324e-03 | 2.285 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.411097e-03 | 2.267 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.483621e-03 | 2.261 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.921142e-03 | 2.228 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.921142e-03 | 2.228 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.543368e-03 | 2.184 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.023595e-03 | 2.220 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.397694e-03 | 2.194 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.543368e-03 | 2.184 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.152205e-03 | 2.211 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.698455e-03 | 2.174 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.725049e-03 | 2.172 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.823058e-03 | 2.166 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.014298e-03 | 2.154 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.367789e-03 | 2.133 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.367789e-03 | 2.133 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.430030e-03 | 2.129 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.430030e-03 | 2.129 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.043806e-03 | 2.095 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.853543e-03 | 2.053 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.853543e-03 | 2.053 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.117591e-03 | 2.091 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.117591e-03 | 2.091 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.169488e-03 | 2.088 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.117591e-03 | 2.091 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.082083e-03 | 2.042 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.082083e-03 | 2.042 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.082083e-03 | 2.042 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.261528e-03 | 2.033 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.629814e-03 | 2.016 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.763296e-03 | 2.010 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.009283e-02 | 1.996 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.078427e-02 | 1.967 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.056363e-02 | 1.976 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.084999e-02 | 1.965 | 1 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.111002e-02 | 1.954 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.111002e-02 | 1.954 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.138707e-02 | 1.944 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.165848e-02 | 1.933 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.169051e-02 | 1.932 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.183656e-02 | 1.927 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.199400e-02 | 1.921 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.206133e-02 | 1.919 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.209237e-02 | 1.917 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.209531e-02 | 1.917 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.234629e-02 | 1.908 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.235736e-02 | 1.908 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.316132e-02 | 1.881 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.316132e-02 | 1.881 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.323134e-02 | 1.878 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.323134e-02 | 1.878 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.323134e-02 | 1.878 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.409908e-02 | 1.851 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.428640e-02 | 1.845 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.270136e-02 | 1.896 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.418682e-02 | 1.848 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.383770e-02 | 1.859 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.317381e-02 | 1.880 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.469768e-02 | 1.833 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.473416e-02 | 1.832 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.496309e-02 | 1.825 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.496309e-02 | 1.825 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.509634e-02 | 1.821 | 1 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.548841e-02 | 1.810 | 1 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.576635e-02 | 1.802 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.578378e-02 | 1.802 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.578378e-02 | 1.802 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.578378e-02 | 1.802 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.626041e-02 | 1.789 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.626041e-02 | 1.789 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.629098e-02 | 1.788 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.644718e-02 | 1.784 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.869173e-02 | 1.728 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.658673e-02 | 1.780 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.714438e-02 | 1.766 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.880289e-02 | 1.726 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.880289e-02 | 1.726 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.907547e-02 | 1.720 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.920257e-02 | 1.717 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.986879e-02 | 1.702 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.986879e-02 | 1.702 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.040460e-02 | 1.690 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.049557e-02 | 1.688 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.076221e-02 | 1.683 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.076221e-02 | 1.683 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.076221e-02 | 1.683 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.078876e-02 | 1.682 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.114720e-02 | 1.675 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.114720e-02 | 1.675 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.114720e-02 | 1.675 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.114720e-02 | 1.675 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.114720e-02 | 1.675 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.193016e-02 | 1.659 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.332780e-02 | 1.632 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.332780e-02 | 1.632 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.449550e-02 | 1.611 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.545575e-02 | 1.594 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.545575e-02 | 1.594 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.304441e-02 | 1.637 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.198255e-02 | 1.658 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.445834e-02 | 1.612 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.198255e-02 | 1.658 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.198255e-02 | 1.658 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.490631e-02 | 1.604 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.560117e-02 | 1.592 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.569747e-02 | 1.590 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.686180e-02 | 1.571 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.782738e-02 | 1.556 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.792830e-02 | 1.554 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.857652e-02 | 1.544 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.891211e-02 | 1.539 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.909574e-02 | 1.536 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.971656e-02 | 1.527 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.971656e-02 | 1.527 | 1 | 1 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.981850e-02 | 1.526 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.032799e-02 | 1.518 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.032799e-02 | 1.518 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.093950e-02 | 1.509 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.115584e-02 | 1.506 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.121955e-02 | 1.506 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.470523e-02 | 1.460 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.470523e-02 | 1.460 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.470523e-02 | 1.460 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.470523e-02 | 1.460 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.470523e-02 | 1.460 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.470523e-02 | 1.460 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.470523e-02 | 1.460 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.470523e-02 | 1.460 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.719143e-02 | 1.430 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.719143e-02 | 1.430 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.719143e-02 | 1.430 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.212378e-02 | 1.493 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.212378e-02 | 1.493 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.839929e-02 | 1.416 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.349671e-02 | 1.475 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.463065e-02 | 1.461 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.310314e-02 | 1.480 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.303132e-02 | 1.481 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.387217e-02 | 1.470 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.303132e-02 | 1.481 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.212378e-02 | 1.493 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.566255e-02 | 1.448 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.212378e-02 | 1.493 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.802306e-02 | 1.420 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.957397e-02 | 1.403 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.957397e-02 | 1.403 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.978749e-02 | 1.400 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.274481e-02 | 1.369 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.274481e-02 | 1.369 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.300117e-02 | 1.367 | 1 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.349600e-02 | 1.362 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.349600e-02 | 1.362 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.349600e-02 | 1.362 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.376389e-02 | 1.359 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.376389e-02 | 1.359 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.382130e-02 | 1.358 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.382130e-02 | 1.358 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.494978e-02 | 1.347 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.507199e-02 | 1.346 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.600160e-02 | 1.337 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.600160e-02 | 1.337 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.677385e-02 | 1.330 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.761899e-02 | 1.322 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.765346e-02 | 1.322 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.830907e-02 | 1.316 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.869231e-02 | 1.313 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.939899e-02 | 1.306 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.076263e-02 | 1.294 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.117468e-02 | 1.291 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.306719e-02 | 1.275 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.309400e-02 | 1.275 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.359977e-02 | 1.271 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.393031e-02 | 1.268 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.393031e-02 | 1.268 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.466181e-02 | 1.262 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.551435e-02 | 1.256 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.791978e-02 | 1.237 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.791978e-02 | 1.237 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.791978e-02 | 1.237 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.791978e-02 | 1.237 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.791978e-02 | 1.237 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.939809e-02 | 1.226 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.939809e-02 | 1.226 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.939809e-02 | 1.226 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.963792e-02 | 1.157 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.963792e-02 | 1.157 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.105089e-02 | 1.214 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.350854e-02 | 1.197 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.241315e-02 | 1.205 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.689263e-02 | 1.175 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.923615e-02 | 1.160 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.577458e-02 | 1.182 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.105089e-02 | 1.214 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.350854e-02 | 1.197 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.791978e-02 | 1.237 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.050875e-02 | 1.218 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.923615e-02 | 1.160 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.577458e-02 | 1.182 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.185616e-02 | 1.209 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.045368e-02 | 1.152 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 7.111134e-02 | 1.148 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 7.111134e-02 | 1.148 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 7.111134e-02 | 1.148 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.246062e-02 | 1.140 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.278025e-02 | 1.138 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.367719e-02 | 1.133 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.507906e-02 | 1.124 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.630446e-02 | 1.117 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.646554e-02 | 1.117 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.665941e-02 | 1.115 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.797236e-02 | 1.108 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.797236e-02 | 1.108 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.939956e-02 | 1.100 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.977011e-02 | 1.098 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.028444e-02 | 1.095 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.109077e-02 | 1.091 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.296524e-02 | 1.081 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.296524e-02 | 1.081 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 8.296524e-02 | 1.081 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.302142e-02 | 1.081 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.302142e-02 | 1.081 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.338430e-02 | 1.079 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.542836e-02 | 1.068 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.582927e-02 | 1.066 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.589678e-02 | 1.066 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.772982e-02 | 1.057 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.780594e-02 | 1.056 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.780594e-02 | 1.056 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.826366e-02 | 1.054 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.826366e-02 | 1.054 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.826366e-02 | 1.054 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.981025e-02 | 1.047 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.081792e-02 | 1.042 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.412677e-02 | 1.026 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.412677e-02 | 1.026 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.519499e-02 | 1.021 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.573413e-02 | 1.019 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.598341e-02 | 1.018 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.819092e-02 | 1.008 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 9.908396e-02 | 1.004 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.908396e-02 | 1.004 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.947310e-02 | 1.002 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.000864e-01 | 1.000 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.152682e-01 | 0.938 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.152682e-01 | 0.938 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.152682e-01 | 0.938 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.118144e-01 | 0.952 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.118144e-01 | 0.952 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.118144e-01 | 0.952 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.225400e-01 | 0.912 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.237354e-01 | 0.908 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 1.039865e-01 | 0.983 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.039865e-01 | 0.983 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.016761e-01 | 0.993 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.166634e-01 | 0.933 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.313497e-01 | 0.882 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.149403e-01 | 0.940 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.248045e-01 | 0.904 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.210618e-01 | 0.917 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.210618e-01 | 0.917 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.166634e-01 | 0.933 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.237354e-01 | 0.908 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.123881e-01 | 0.949 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.115022e-01 | 0.953 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.187947e-01 | 0.925 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.060551e-01 | 0.974 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.118144e-01 | 0.952 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.225400e-01 | 0.912 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.265955e-01 | 0.898 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.236979e-01 | 0.908 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.283213e-01 | 0.892 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.115022e-01 | 0.953 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.039602e-01 | 0.983 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.271554e-01 | 0.896 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.039865e-01 | 0.983 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.237354e-01 | 0.908 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.166484e-01 | 0.933 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.337021e-01 | 0.874 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.120556e-01 | 0.951 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.045863e-01 | 0.981 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.323155e-01 | 0.878 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.167616e-01 | 0.933 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.290909e-01 | 0.889 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.337021e-01 | 0.874 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.016761e-01 | 0.993 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.092756e-01 | 0.961 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.152322e-01 | 0.938 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.137445e-01 | 0.944 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.225400e-01 | 0.912 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.166484e-01 | 0.933 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.166634e-01 | 0.933 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.079431e-01 | 0.967 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.045895e-01 | 0.981 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.118144e-01 | 0.952 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.349314e-01 | 0.870 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.349314e-01 | 0.870 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.349314e-01 | 0.870 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.349314e-01 | 0.870 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.349314e-01 | 0.870 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.349314e-01 | 0.870 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.349314e-01 | 0.870 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.349314e-01 | 0.870 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.349314e-01 | 0.870 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.349314e-01 | 0.870 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.351382e-01 | 0.869 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.353880e-01 | 0.868 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.394233e-01 | 0.856 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.401350e-01 | 0.853 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.408778e-01 | 0.851 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.408778e-01 | 0.851 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.451034e-01 | 0.838 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.451034e-01 | 0.838 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.451034e-01 | 0.838 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.451034e-01 | 0.838 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.464896e-01 | 0.834 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.468373e-01 | 0.833 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.481040e-01 | 0.829 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.481040e-01 | 0.829 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.481040e-01 | 0.829 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.481040e-01 | 0.829 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.481040e-01 | 0.829 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.498263e-01 | 0.824 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.498263e-01 | 0.824 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.498263e-01 | 0.824 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.498263e-01 | 0.824 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.498263e-01 | 0.824 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.506825e-01 | 0.822 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.534962e-01 | 0.814 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.534962e-01 | 0.814 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.567862e-01 | 0.805 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.568741e-01 | 0.804 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.568741e-01 | 0.804 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.572173e-01 | 0.803 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.573715e-01 | 0.803 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.589898e-01 | 0.799 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.589898e-01 | 0.799 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.589898e-01 | 0.799 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.607193e-01 | 0.794 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.622165e-01 | 0.790 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.644232e-01 | 0.784 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.669619e-01 | 0.777 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.516630e-01 | 0.599 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.516630e-01 | 0.599 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.516630e-01 | 0.599 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.516630e-01 | 0.599 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.516630e-01 | 0.599 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.516630e-01 | 0.599 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.516630e-01 | 0.599 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.516630e-01 | 0.599 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.164248e-01 | 0.665 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.164248e-01 | 0.665 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.164248e-01 | 0.665 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.164248e-01 | 0.665 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.164248e-01 | 0.665 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.164248e-01 | 0.665 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.785254e-01 | 0.748 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.785254e-01 | 0.748 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.785254e-01 | 0.748 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.785254e-01 | 0.748 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.785254e-01 | 0.748 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.785254e-01 | 0.748 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.151496e-01 | 0.667 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.151496e-01 | 0.667 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.151496e-01 | 0.667 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.151496e-01 | 0.667 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.755096e-01 | 0.756 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.755096e-01 | 0.756 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.755096e-01 | 0.756 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.679237e-01 | 0.775 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.044721e-01 | 0.689 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.044721e-01 | 0.689 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.044721e-01 | 0.689 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.044721e-01 | 0.689 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.044721e-01 | 0.689 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.044721e-01 | 0.689 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.044721e-01 | 0.689 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.044721e-01 | 0.689 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.044721e-01 | 0.689 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.920398e-01 | 0.717 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.920398e-01 | 0.717 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.172834e-01 | 0.663 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.013509e-01 | 0.696 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.868637e-01 | 0.728 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.434791e-01 | 0.614 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.239284e-01 | 0.650 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.239284e-01 | 0.650 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.066617e-01 | 0.685 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.066617e-01 | 0.685 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.066617e-01 | 0.685 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.774129e-01 | 0.751 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.774129e-01 | 0.751 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.472814e-01 | 0.607 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.272065e-01 | 0.644 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.272065e-01 | 0.644 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.272065e-01 | 0.644 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.272065e-01 | 0.644 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.484124e-01 | 0.605 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.484124e-01 | 0.605 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.064249e-01 | 0.685 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.041129e-01 | 0.690 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.774129e-01 | 0.751 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.013509e-01 | 0.696 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.461115e-01 | 0.609 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.868637e-01 | 0.728 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.434791e-01 | 0.614 | 1 | 1 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.144263e-01 | 0.669 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.002500e-01 | 0.698 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.921577e-01 | 0.716 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.679237e-01 | 0.775 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.679237e-01 | 0.775 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.239284e-01 | 0.650 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.789560e-01 | 0.747 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.239284e-01 | 0.650 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.789560e-01 | 0.747 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.908773e-01 | 0.719 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.678935e-01 | 0.775 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.242363e-01 | 0.649 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.151496e-01 | 0.667 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.736851e-01 | 0.760 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.425339e-01 | 0.615 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.051771e-01 | 0.688 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.396110e-01 | 0.620 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.044721e-01 | 0.689 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.021698e-01 | 0.694 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.242363e-01 | 0.649 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.516630e-01 | 0.599 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.044721e-01 | 0.689 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.920398e-01 | 0.717 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.275670e-01 | 0.643 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.220791e-01 | 0.653 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.797105e-01 | 0.745 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.809833e-01 | 0.742 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.369492e-01 | 0.625 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.272717e-01 | 0.643 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.184623e-01 | 0.661 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.146062e-01 | 0.668 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.785254e-01 | 0.748 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.336475e-01 | 0.631 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.002500e-01 | 0.698 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.479748e-01 | 0.606 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.081304e-01 | 0.682 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.095409e-01 | 0.679 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.981670e-01 | 0.703 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.320403e-01 | 0.634 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.516630e-01 | 0.599 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.516630e-01 | 0.599 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.516630e-01 | 0.599 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.164248e-01 | 0.665 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.755096e-01 | 0.756 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.484124e-01 | 0.605 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.945825e-01 | 0.711 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.951228e-01 | 0.710 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.066617e-01 | 0.685 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.472814e-01 | 0.607 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.117754e-01 | 0.674 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.774129e-01 | 0.751 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.831057e-01 | 0.737 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.284442e-01 | 0.641 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.785254e-01 | 0.748 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.921577e-01 | 0.716 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.044721e-01 | 0.689 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.284677e-01 | 0.641 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.045090e-01 | 0.689 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.755096e-01 | 0.756 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.472814e-01 | 0.607 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.095409e-01 | 0.679 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.434791e-01 | 0.614 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.932761e-01 | 0.714 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.108466e-01 | 0.676 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.785254e-01 | 0.748 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.013509e-01 | 0.696 | 1 | 1 |
| ARMS-mediated activation | R-HSA-170984 | 2.531604e-01 | 0.597 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.531604e-01 | 0.597 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.531604e-01 | 0.597 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.531604e-01 | 0.597 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.531604e-01 | 0.597 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.531604e-01 | 0.597 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.569041e-01 | 0.590 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.584144e-01 | 0.588 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.584144e-01 | 0.588 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.616330e-01 | 0.582 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.526488e-01 | 0.453 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.526488e-01 | 0.453 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.526488e-01 | 0.453 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 3.526488e-01 | 0.453 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.526488e-01 | 0.453 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.526488e-01 | 0.453 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.696108e-01 | 0.569 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.696108e-01 | 0.569 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.227153e-01 | 0.491 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.227153e-01 | 0.491 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.227153e-01 | 0.491 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.400119e-01 | 0.357 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.400119e-01 | 0.357 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.400119e-01 | 0.357 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.400119e-01 | 0.357 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.400119e-01 | 0.357 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.400119e-01 | 0.357 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.920155e-01 | 0.535 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.920155e-01 | 0.535 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.920155e-01 | 0.535 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.659003e-01 | 0.575 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.747925e-01 | 0.426 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.747925e-01 | 0.426 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.747925e-01 | 0.426 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.747925e-01 | 0.426 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.312265e-01 | 0.480 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.312265e-01 | 0.480 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.977914e-01 | 0.526 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.977914e-01 | 0.526 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.977914e-01 | 0.526 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.977914e-01 | 0.526 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.977914e-01 | 0.526 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.980142e-01 | 0.526 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.301028e-01 | 0.481 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.301028e-01 | 0.481 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.301028e-01 | 0.481 | 1 | 1 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.301028e-01 | 0.481 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.703631e-01 | 0.431 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.703631e-01 | 0.431 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.703631e-01 | 0.431 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.251528e-01 | 0.371 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.251528e-01 | 0.371 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.251528e-01 | 0.371 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.155893e-01 | 0.288 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.155893e-01 | 0.288 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.155893e-01 | 0.288 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.155893e-01 | 0.288 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.155893e-01 | 0.288 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.155893e-01 | 0.288 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 5.155893e-01 | 0.288 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.155893e-01 | 0.288 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.155893e-01 | 0.288 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.155893e-01 | 0.288 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.701903e-01 | 0.568 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.260012e-01 | 0.487 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.260012e-01 | 0.487 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.625821e-01 | 0.441 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.090540e-01 | 0.388 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.090540e-01 | 0.388 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.090540e-01 | 0.388 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.090540e-01 | 0.388 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.542417e-01 | 0.451 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.459996e-01 | 0.461 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.949976e-01 | 0.403 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.733114e-01 | 0.325 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.733114e-01 | 0.325 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.733114e-01 | 0.325 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.733114e-01 | 0.325 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.733114e-01 | 0.325 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.733114e-01 | 0.325 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.751299e-01 | 0.560 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.825757e-01 | 0.417 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.469863e-01 | 0.350 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.469863e-01 | 0.350 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.271394e-01 | 0.369 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.061112e-01 | 0.514 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.844696e-01 | 0.415 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.082979e-01 | 0.511 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.627464e-01 | 0.440 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.389355e-01 | 0.358 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.389355e-01 | 0.358 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.588212e-01 | 0.338 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.588212e-01 | 0.338 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.588212e-01 | 0.338 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.189455e-01 | 0.285 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.189455e-01 | 0.285 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.189455e-01 | 0.285 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.189455e-01 | 0.285 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.959475e-01 | 0.529 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.916730e-01 | 0.407 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.916730e-01 | 0.407 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.388429e-01 | 0.470 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.898798e-01 | 0.310 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.809299e-01 | 0.419 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.195922e-01 | 0.284 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.195922e-01 | 0.284 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.195922e-01 | 0.284 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.940190e-01 | 0.306 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.042479e-01 | 0.393 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.208043e-01 | 0.283 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.221404e-01 | 0.282 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.221404e-01 | 0.282 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.221404e-01 | 0.282 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.221404e-01 | 0.282 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.071935e-01 | 0.295 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.228198e-01 | 0.282 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.127546e-01 | 0.505 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.388429e-01 | 0.470 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.161626e-01 | 0.500 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.271394e-01 | 0.369 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.380433e-01 | 0.471 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.725194e-01 | 0.326 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.221404e-01 | 0.282 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.980142e-01 | 0.526 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.825757e-01 | 0.417 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.771138e-01 | 0.321 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.949976e-01 | 0.403 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.703631e-01 | 0.431 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.260012e-01 | 0.487 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.350625e-01 | 0.475 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.380433e-01 | 0.471 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.841145e-01 | 0.315 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.221404e-01 | 0.282 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.703631e-01 | 0.431 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.625821e-01 | 0.441 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.971965e-01 | 0.303 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.019937e-01 | 0.299 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.222588e-01 | 0.374 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.839015e-01 | 0.315 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.490152e-01 | 0.348 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.920155e-01 | 0.535 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.352514e-01 | 0.361 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.841402e-01 | 0.546 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.441068e-01 | 0.353 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.019937e-01 | 0.299 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.197224e-01 | 0.495 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.920155e-01 | 0.535 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.711756e-01 | 0.567 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.997900e-01 | 0.301 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.772014e-01 | 0.321 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.997594e-01 | 0.523 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.210394e-01 | 0.376 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.535653e-01 | 0.452 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.920155e-01 | 0.535 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.625821e-01 | 0.441 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.090540e-01 | 0.388 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.732969e-01 | 0.428 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.189455e-01 | 0.285 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.189455e-01 | 0.285 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.940190e-01 | 0.306 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.389355e-01 | 0.358 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.704487e-01 | 0.568 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.509218e-01 | 0.346 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.966805e-01 | 0.402 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.651456e-01 | 0.577 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.197224e-01 | 0.495 | 1 | 1 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.725194e-01 | 0.326 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.647464e-01 | 0.333 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.134338e-01 | 0.290 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 2.696108e-01 | 0.569 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.155893e-01 | 0.288 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.207691e-01 | 0.494 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.949976e-01 | 0.403 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.733114e-01 | 0.325 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.839015e-01 | 0.315 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.839015e-01 | 0.315 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.647464e-01 | 0.333 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.042711e-01 | 0.297 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.249712e-01 | 0.280 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.969495e-01 | 0.527 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.042711e-01 | 0.297 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.296814e-01 | 0.482 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.977914e-01 | 0.526 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.147817e-01 | 0.502 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.002803e-01 | 0.301 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.189455e-01 | 0.285 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.809299e-01 | 0.419 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.726422e-01 | 0.429 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.227153e-01 | 0.491 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.703631e-01 | 0.431 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.260012e-01 | 0.487 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.762072e-01 | 0.559 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.165269e-01 | 0.380 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.725194e-01 | 0.326 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.284236e-01 | 0.368 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.892021e-01 | 0.539 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.958249e-01 | 0.529 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.747925e-01 | 0.426 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.704487e-01 | 0.568 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.733114e-01 | 0.325 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.775745e-01 | 0.557 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.030925e-01 | 0.518 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.892687e-01 | 0.539 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.611967e-01 | 0.442 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.236069e-01 | 0.281 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.940190e-01 | 0.306 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.599382e-01 | 0.337 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.971965e-01 | 0.303 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.140025e-01 | 0.383 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.572370e-01 | 0.340 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.904148e-01 | 0.537 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.140025e-01 | 0.383 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.140025e-01 | 0.383 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.526488e-01 | 0.453 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.526488e-01 | 0.453 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.696108e-01 | 0.569 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.227153e-01 | 0.491 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.227153e-01 | 0.491 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.400119e-01 | 0.357 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.400119e-01 | 0.357 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.400119e-01 | 0.357 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.400119e-01 | 0.357 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.400119e-01 | 0.357 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.400119e-01 | 0.357 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.312265e-01 | 0.480 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.251528e-01 | 0.371 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.155893e-01 | 0.288 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 5.155893e-01 | 0.288 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.207691e-01 | 0.494 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.090540e-01 | 0.388 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.090540e-01 | 0.388 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.733114e-01 | 0.325 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.271394e-01 | 0.369 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.271394e-01 | 0.369 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.189455e-01 | 0.285 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.944342e-01 | 0.404 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.087643e-01 | 0.293 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.310373e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.208043e-01 | 0.283 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.542417e-01 | 0.451 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.195922e-01 | 0.284 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.380433e-01 | 0.471 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.985309e-01 | 0.400 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.488165e-01 | 0.348 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.312265e-01 | 0.480 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.090540e-01 | 0.388 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.588212e-01 | 0.338 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.459996e-01 | 0.461 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.884560e-01 | 0.540 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.533814e-01 | 0.344 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.533814e-01 | 0.344 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.839015e-01 | 0.315 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.975095e-01 | 0.303 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.884560e-01 | 0.540 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.977914e-01 | 0.526 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.949014e-01 | 0.404 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.958249e-01 | 0.529 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.469863e-01 | 0.350 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.365584e-01 | 0.473 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.271394e-01 | 0.369 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.526488e-01 | 0.453 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.526488e-01 | 0.453 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.400119e-01 | 0.357 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.920155e-01 | 0.535 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.733114e-01 | 0.325 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.469863e-01 | 0.350 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.469863e-01 | 0.350 | 1 | 1 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.201753e-01 | 0.284 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.920155e-01 | 0.535 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.469863e-01 | 0.350 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.704487e-01 | 0.568 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.270540e-01 | 0.485 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.127546e-01 | 0.505 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.636000e-01 | 0.579 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.195922e-01 | 0.284 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.201753e-01 | 0.284 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.201753e-01 | 0.284 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.351989e-01 | 0.361 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.696108e-01 | 0.569 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.733114e-01 | 0.325 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.189455e-01 | 0.285 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.382387e-01 | 0.358 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.920155e-01 | 0.535 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.936294e-01 | 0.307 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.832599e-01 | 0.417 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.251528e-01 | 0.371 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.844696e-01 | 0.415 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.189455e-01 | 0.285 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.189455e-01 | 0.285 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.195922e-01 | 0.284 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.056371e-01 | 0.296 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.459438e-01 | 0.351 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.271394e-01 | 0.369 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.380433e-01 | 0.471 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.270540e-01 | 0.485 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.108533e-01 | 0.386 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.588212e-01 | 0.338 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.254778e-01 | 0.279 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.360253e-01 | 0.271 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.421538e-01 | 0.266 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.424635e-01 | 0.266 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.428053e-01 | 0.265 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.452550e-01 | 0.263 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.452550e-01 | 0.263 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.452550e-01 | 0.263 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.469626e-01 | 0.262 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.469626e-01 | 0.262 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.495901e-01 | 0.260 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.495901e-01 | 0.260 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.538973e-01 | 0.257 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.538973e-01 | 0.257 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.538973e-01 | 0.257 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.538973e-01 | 0.257 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.538973e-01 | 0.257 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.538973e-01 | 0.257 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.538973e-01 | 0.257 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.558995e-01 | 0.255 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.566623e-01 | 0.254 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.586241e-01 | 0.253 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.604976e-01 | 0.251 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.618097e-01 | 0.250 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.618593e-01 | 0.250 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.618593e-01 | 0.250 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.618593e-01 | 0.250 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.618593e-01 | 0.250 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.618593e-01 | 0.250 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.618593e-01 | 0.250 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.618593e-01 | 0.250 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.634808e-01 | 0.249 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.656431e-01 | 0.247 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.656431e-01 | 0.247 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.656431e-01 | 0.247 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.674276e-01 | 0.246 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.685049e-01 | 0.245 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.685049e-01 | 0.245 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.685049e-01 | 0.245 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.701067e-01 | 0.244 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.724172e-01 | 0.242 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.724172e-01 | 0.242 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.724172e-01 | 0.242 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.724172e-01 | 0.242 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.724172e-01 | 0.242 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.763977e-01 | 0.239 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.780275e-01 | 0.238 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.780275e-01 | 0.238 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.780275e-01 | 0.238 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.780275e-01 | 0.238 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.804759e-01 | 0.236 | 0 | 0 |
| Alternative complement activation | R-HSA-173736 | 5.809704e-01 | 0.236 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.809704e-01 | 0.236 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.809704e-01 | 0.236 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.809704e-01 | 0.236 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.809704e-01 | 0.236 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.809704e-01 | 0.236 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.809704e-01 | 0.236 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.809704e-01 | 0.236 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.809704e-01 | 0.236 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.809704e-01 | 0.236 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.809704e-01 | 0.236 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.809704e-01 | 0.236 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.809704e-01 | 0.236 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.809704e-01 | 0.236 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.811458e-01 | 0.236 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.818802e-01 | 0.235 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.851617e-01 | 0.233 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.866971e-01 | 0.232 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.866971e-01 | 0.232 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.873556e-01 | 0.231 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.908564e-01 | 0.229 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.911607e-01 | 0.228 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.911607e-01 | 0.228 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.956601e-01 | 0.225 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.970296e-01 | 0.224 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.971038e-01 | 0.224 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.971038e-01 | 0.224 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.971038e-01 | 0.224 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.987734e-01 | 0.223 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.991436e-01 | 0.222 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.997246e-01 | 0.222 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.019560e-01 | 0.220 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.019560e-01 | 0.220 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.019560e-01 | 0.220 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.019560e-01 | 0.220 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.019560e-01 | 0.220 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.019560e-01 | 0.220 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.025548e-01 | 0.220 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.054110e-01 | 0.218 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.054110e-01 | 0.218 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.054110e-01 | 0.218 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.072360e-01 | 0.217 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.126809e-01 | 0.213 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.127371e-01 | 0.213 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.131764e-01 | 0.212 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.131764e-01 | 0.212 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.179080e-01 | 0.209 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.179080e-01 | 0.209 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.209695e-01 | 0.207 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.212522e-01 | 0.207 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.214123e-01 | 0.207 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.245384e-01 | 0.204 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.264635e-01 | 0.203 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.274011e-01 | 0.202 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.280466e-01 | 0.202 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.316820e-01 | 0.200 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.371348e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.375302e-01 | 0.195 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.375302e-01 | 0.195 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.375302e-01 | 0.195 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 6.375302e-01 | 0.195 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.375302e-01 | 0.195 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.375302e-01 | 0.195 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.375302e-01 | 0.195 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.375302e-01 | 0.195 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.375302e-01 | 0.195 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 6.375302e-01 | 0.195 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.375302e-01 | 0.195 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.375302e-01 | 0.195 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.375302e-01 | 0.195 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.375302e-01 | 0.195 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.392141e-01 | 0.194 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.392141e-01 | 0.194 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.392141e-01 | 0.194 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 6.392141e-01 | 0.194 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.392141e-01 | 0.194 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.392141e-01 | 0.194 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.392141e-01 | 0.194 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.392141e-01 | 0.194 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.397799e-01 | 0.194 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.411396e-01 | 0.193 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.436582e-01 | 0.191 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.439721e-01 | 0.191 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.439721e-01 | 0.191 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.466213e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.474784e-01 | 0.189 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.474784e-01 | 0.189 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.474784e-01 | 0.189 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.474784e-01 | 0.189 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.474784e-01 | 0.189 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.479670e-01 | 0.188 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.507069e-01 | 0.187 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.533167e-01 | 0.185 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.564741e-01 | 0.183 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.564741e-01 | 0.183 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.567988e-01 | 0.183 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.567988e-01 | 0.183 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.616947e-01 | 0.179 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.653826e-01 | 0.177 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.660796e-01 | 0.176 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.660796e-01 | 0.176 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.729600e-01 | 0.172 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.729600e-01 | 0.172 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.729600e-01 | 0.172 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.736694e-01 | 0.172 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.736694e-01 | 0.172 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.736694e-01 | 0.172 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.736694e-01 | 0.172 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.736694e-01 | 0.172 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.736694e-01 | 0.172 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.736694e-01 | 0.172 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.736694e-01 | 0.172 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.736694e-01 | 0.172 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.736694e-01 | 0.172 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.736694e-01 | 0.172 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.736694e-01 | 0.172 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.750324e-01 | 0.171 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.750324e-01 | 0.171 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.753836e-01 | 0.170 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.753836e-01 | 0.170 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.753836e-01 | 0.170 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.753836e-01 | 0.170 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.753836e-01 | 0.170 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.807343e-01 | 0.167 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.807343e-01 | 0.167 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.835850e-01 | 0.165 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.864585e-01 | 0.163 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.864585e-01 | 0.163 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.864585e-01 | 0.163 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.864585e-01 | 0.163 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.864585e-01 | 0.163 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.864585e-01 | 0.163 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.864585e-01 | 0.163 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.864585e-01 | 0.163 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.864585e-01 | 0.163 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.864585e-01 | 0.163 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.864585e-01 | 0.163 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.864585e-01 | 0.163 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.864585e-01 | 0.163 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.864585e-01 | 0.163 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.864585e-01 | 0.163 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.917342e-01 | 0.160 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.922735e-01 | 0.160 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.926887e-01 | 0.159 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.941714e-01 | 0.159 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.941714e-01 | 0.159 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.994996e-01 | 0.155 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.016218e-01 | 0.154 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.016218e-01 | 0.154 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.016218e-01 | 0.154 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.034751e-01 | 0.153 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.034751e-01 | 0.153 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.034751e-01 | 0.153 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.048316e-01 | 0.152 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.048316e-01 | 0.152 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.053996e-01 | 0.152 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.053996e-01 | 0.152 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.053996e-01 | 0.152 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.069078e-01 | 0.151 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.075273e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.075273e-01 | 0.150 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.075273e-01 | 0.150 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.075273e-01 | 0.150 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.075273e-01 | 0.150 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.079513e-01 | 0.150 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.095985e-01 | 0.149 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.125449e-01 | 0.147 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.148782e-01 | 0.146 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.236006e-01 | 0.141 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.250193e-01 | 0.140 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.250193e-01 | 0.140 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.250193e-01 | 0.140 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.250193e-01 | 0.140 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.262101e-01 | 0.139 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.262101e-01 | 0.139 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.262101e-01 | 0.139 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.262101e-01 | 0.139 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.268470e-01 | 0.139 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.273616e-01 | 0.138 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.287846e-01 | 0.137 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.287846e-01 | 0.137 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.287846e-01 | 0.137 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.287846e-01 | 0.137 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.287846e-01 | 0.137 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.287846e-01 | 0.137 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 7.287846e-01 | 0.137 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.287846e-01 | 0.137 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.287846e-01 | 0.137 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.287846e-01 | 0.137 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.287846e-01 | 0.137 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.287846e-01 | 0.137 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.287846e-01 | 0.137 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.287846e-01 | 0.137 | 1 | 1 |
| HDL clearance | R-HSA-8964011 | 7.287846e-01 | 0.137 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.301459e-01 | 0.137 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.334917e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.342098e-01 | 0.134 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.345124e-01 | 0.134 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.345124e-01 | 0.134 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.345124e-01 | 0.134 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.345124e-01 | 0.134 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 7.345124e-01 | 0.134 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.345124e-01 | 0.134 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.348260e-01 | 0.134 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.386766e-01 | 0.132 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.428614e-01 | 0.129 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.452291e-01 | 0.128 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.453751e-01 | 0.128 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.453751e-01 | 0.128 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.486460e-01 | 0.126 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.486912e-01 | 0.126 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.491814e-01 | 0.125 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.491814e-01 | 0.125 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.491814e-01 | 0.125 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.531763e-01 | 0.123 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.531763e-01 | 0.123 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.540853e-01 | 0.123 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.569422e-01 | 0.121 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.576059e-01 | 0.121 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.593400e-01 | 0.120 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.611363e-01 | 0.119 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.611363e-01 | 0.119 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.611363e-01 | 0.119 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.611363e-01 | 0.119 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.611363e-01 | 0.119 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.611363e-01 | 0.119 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.611363e-01 | 0.119 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.611363e-01 | 0.119 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.630266e-01 | 0.117 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.645595e-01 | 0.117 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.645595e-01 | 0.117 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.646680e-01 | 0.117 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.653991e-01 | 0.116 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.653991e-01 | 0.116 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.653991e-01 | 0.116 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.653991e-01 | 0.116 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.653991e-01 | 0.116 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.653991e-01 | 0.116 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.653991e-01 | 0.116 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.653991e-01 | 0.116 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.653991e-01 | 0.116 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.653991e-01 | 0.116 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.653991e-01 | 0.116 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.653991e-01 | 0.116 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.653991e-01 | 0.116 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.653991e-01 | 0.116 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.653991e-01 | 0.116 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.653991e-01 | 0.116 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.687684e-01 | 0.114 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.705806e-01 | 0.113 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.705806e-01 | 0.113 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.706589e-01 | 0.113 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.783151e-01 | 0.109 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.789111e-01 | 0.109 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.792120e-01 | 0.108 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.804490e-01 | 0.108 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.825966e-01 | 0.106 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.825966e-01 | 0.106 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.854125e-01 | 0.105 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.854125e-01 | 0.105 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.854125e-01 | 0.105 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.854125e-01 | 0.105 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.854125e-01 | 0.105 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.854125e-01 | 0.105 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.854125e-01 | 0.105 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.879892e-01 | 0.103 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.904624e-01 | 0.102 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.928479e-01 | 0.101 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.948415e-01 | 0.100 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.948415e-01 | 0.100 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.948415e-01 | 0.100 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.968664e-01 | 0.099 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.970724e-01 | 0.099 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.970724e-01 | 0.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.970724e-01 | 0.099 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.970724e-01 | 0.099 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.970724e-01 | 0.099 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.970724e-01 | 0.099 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.970724e-01 | 0.099 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.970724e-01 | 0.099 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.970724e-01 | 0.099 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.970724e-01 | 0.099 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.970724e-01 | 0.099 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.970724e-01 | 0.099 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.970724e-01 | 0.099 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 7.970724e-01 | 0.099 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.970724e-01 | 0.099 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.054451e-01 | 0.094 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.066381e-01 | 0.093 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.074379e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.074895e-01 | 0.093 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.074895e-01 | 0.093 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.084956e-01 | 0.092 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.088887e-01 | 0.092 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.088887e-01 | 0.092 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.088887e-01 | 0.092 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.095893e-01 | 0.092 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.095893e-01 | 0.092 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.123839e-01 | 0.090 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.135838e-01 | 0.090 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.159652e-01 | 0.088 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.171067e-01 | 0.088 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.173004e-01 | 0.088 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.181120e-01 | 0.087 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.197015e-01 | 0.086 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.197015e-01 | 0.086 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.244711e-01 | 0.084 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.244711e-01 | 0.084 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.244711e-01 | 0.084 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.244711e-01 | 0.084 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.244711e-01 | 0.084 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.244711e-01 | 0.084 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.244711e-01 | 0.084 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.244711e-01 | 0.084 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.244711e-01 | 0.084 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.244711e-01 | 0.084 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.244711e-01 | 0.084 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.248016e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.259268e-01 | 0.083 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.259268e-01 | 0.083 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.259268e-01 | 0.083 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.259268e-01 | 0.083 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.259268e-01 | 0.083 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.259268e-01 | 0.083 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.275186e-01 | 0.082 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.275186e-01 | 0.082 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.278810e-01 | 0.082 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.292433e-01 | 0.081 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.301511e-01 | 0.081 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.320563e-01 | 0.080 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.365376e-01 | 0.078 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.416471e-01 | 0.075 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.416471e-01 | 0.075 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.416471e-01 | 0.075 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.416471e-01 | 0.075 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.437224e-01 | 0.074 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.439461e-01 | 0.074 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.439461e-01 | 0.074 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.456503e-01 | 0.073 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.456503e-01 | 0.073 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.456503e-01 | 0.073 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.456503e-01 | 0.073 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.456503e-01 | 0.073 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.456503e-01 | 0.073 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.456503e-01 | 0.073 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.456503e-01 | 0.073 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.481719e-01 | 0.072 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.481719e-01 | 0.072 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.481719e-01 | 0.072 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.481719e-01 | 0.072 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.481719e-01 | 0.072 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.481719e-01 | 0.072 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.481719e-01 | 0.072 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.481719e-01 | 0.072 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.481719e-01 | 0.072 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.481719e-01 | 0.072 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.487937e-01 | 0.071 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.487937e-01 | 0.071 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.511109e-01 | 0.070 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.561223e-01 | 0.067 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.561223e-01 | 0.067 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.569969e-01 | 0.067 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.569969e-01 | 0.067 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.587373e-01 | 0.066 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.602776e-01 | 0.065 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.602776e-01 | 0.065 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.604098e-01 | 0.065 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.610616e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.610616e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.610616e-01 | 0.065 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.610616e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.610616e-01 | 0.065 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.610616e-01 | 0.065 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.620316e-01 | 0.064 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.620316e-01 | 0.064 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.620316e-01 | 0.064 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.620316e-01 | 0.064 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.632973e-01 | 0.064 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.632973e-01 | 0.064 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.650765e-01 | 0.063 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.686736e-01 | 0.061 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.686736e-01 | 0.061 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.686736e-01 | 0.061 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.686736e-01 | 0.061 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.686736e-01 | 0.061 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.686736e-01 | 0.061 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.686736e-01 | 0.061 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.686736e-01 | 0.061 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.686736e-01 | 0.061 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.686736e-01 | 0.061 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.686736e-01 | 0.061 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.687114e-01 | 0.061 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.694256e-01 | 0.061 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.710211e-01 | 0.060 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.710211e-01 | 0.060 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.710211e-01 | 0.060 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.723291e-01 | 0.059 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.743537e-01 | 0.058 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.748113e-01 | 0.058 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.760645e-01 | 0.057 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.760645e-01 | 0.057 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.768046e-01 | 0.057 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.768046e-01 | 0.057 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.768046e-01 | 0.057 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.768046e-01 | 0.057 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.779271e-01 | 0.057 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.779778e-01 | 0.057 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.788302e-01 | 0.056 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.810567e-01 | 0.055 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.810567e-01 | 0.055 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.816822e-01 | 0.055 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.864080e-01 | 0.052 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.864080e-01 | 0.052 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.864080e-01 | 0.052 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.864080e-01 | 0.052 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.864080e-01 | 0.052 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.876358e-01 | 0.052 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.901049e-01 | 0.051 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.901049e-01 | 0.051 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.901049e-01 | 0.051 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.901049e-01 | 0.051 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.904173e-01 | 0.050 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.904173e-01 | 0.050 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.904173e-01 | 0.050 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.918578e-01 | 0.050 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.925189e-01 | 0.049 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.925189e-01 | 0.049 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.964078e-01 | 0.047 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.972399e-01 | 0.047 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.989354e-01 | 0.046 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.991361e-01 | 0.046 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.994871e-01 | 0.046 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.994871e-01 | 0.046 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.005420e-01 | 0.045 | 1 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 9.017484e-01 | 0.045 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.017484e-01 | 0.045 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.017484e-01 | 0.045 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.017484e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.017484e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.017484e-01 | 0.045 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 9.017484e-01 | 0.045 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.017484e-01 | 0.045 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.017484e-01 | 0.045 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.020607e-01 | 0.045 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.020607e-01 | 0.045 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.020607e-01 | 0.045 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.029064e-01 | 0.044 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.030276e-01 | 0.044 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.030276e-01 | 0.044 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.049913e-01 | 0.043 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.072461e-01 | 0.042 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.082307e-01 | 0.042 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.082307e-01 | 0.042 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.082307e-01 | 0.042 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.082307e-01 | 0.042 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.127925e-01 | 0.040 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.127925e-01 | 0.040 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.127925e-01 | 0.040 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.127925e-01 | 0.040 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.127925e-01 | 0.040 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.147799e-01 | 0.039 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.147799e-01 | 0.039 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.147799e-01 | 0.039 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.150179e-01 | 0.039 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.150179e-01 | 0.039 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.150179e-01 | 0.039 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.150179e-01 | 0.039 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.150179e-01 | 0.039 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.150179e-01 | 0.039 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 9.150179e-01 | 0.039 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.150535e-01 | 0.039 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.184192e-01 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.202590e-01 | 0.036 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.208660e-01 | 0.036 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.224128e-01 | 0.035 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.224128e-01 | 0.035 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.241099e-01 | 0.034 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.264959e-01 | 0.033 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.264959e-01 | 0.033 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.264959e-01 | 0.033 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.264959e-01 | 0.033 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.264959e-01 | 0.033 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.264959e-01 | 0.033 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.264959e-01 | 0.033 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.264959e-01 | 0.033 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.264959e-01 | 0.033 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.264959e-01 | 0.033 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.264959e-01 | 0.033 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.264959e-01 | 0.033 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.276850e-01 | 0.033 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.278011e-01 | 0.033 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.286114e-01 | 0.032 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.286114e-01 | 0.032 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.286114e-01 | 0.032 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.290504e-01 | 0.032 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.294540e-01 | 0.032 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.305384e-01 | 0.031 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.310260e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.310260e-01 | 0.031 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.310260e-01 | 0.031 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.334361e-01 | 0.030 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.342415e-01 | 0.030 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.356542e-01 | 0.029 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.364242e-01 | 0.029 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.364242e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.364242e-01 | 0.029 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.364242e-01 | 0.029 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.364242e-01 | 0.029 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.364242e-01 | 0.029 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.364242e-01 | 0.029 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.364242e-01 | 0.029 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.366431e-01 | 0.028 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.374911e-01 | 0.028 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.375382e-01 | 0.028 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.386309e-01 | 0.028 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.387287e-01 | 0.027 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.387287e-01 | 0.027 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.397838e-01 | 0.027 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.397838e-01 | 0.027 | 1 | 1 |
| Regulation of Apoptosis | R-HSA-169911 | 9.420502e-01 | 0.026 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.425554e-01 | 0.026 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.440395e-01 | 0.025 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.449021e-01 | 0.025 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.450120e-01 | 0.025 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.450120e-01 | 0.025 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.450120e-01 | 0.025 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.450120e-01 | 0.025 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.450120e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.450120e-01 | 0.025 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.450120e-01 | 0.025 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.450120e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.450120e-01 | 0.025 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.456095e-01 | 0.024 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.456095e-01 | 0.024 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.478233e-01 | 0.023 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.478233e-01 | 0.023 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.478520e-01 | 0.023 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.478520e-01 | 0.023 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.482642e-01 | 0.023 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.489434e-01 | 0.023 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.492919e-01 | 0.023 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.502712e-01 | 0.022 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.517499e-01 | 0.021 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.517499e-01 | 0.021 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.517499e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.517499e-01 | 0.021 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.519729e-01 | 0.021 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.519729e-01 | 0.021 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.524402e-01 | 0.021 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.524402e-01 | 0.021 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.524402e-01 | 0.021 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.524402e-01 | 0.021 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.524402e-01 | 0.021 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.524402e-01 | 0.021 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.524402e-01 | 0.021 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.524402e-01 | 0.021 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.524402e-01 | 0.021 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.524402e-01 | 0.021 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.524402e-01 | 0.021 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.524402e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.524402e-01 | 0.021 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.524402e-01 | 0.021 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.526448e-01 | 0.021 | 1 | 1 |
| Degradation of AXIN | R-HSA-4641257 | 9.531089e-01 | 0.021 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.531089e-01 | 0.021 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.551270e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.561934e-01 | 0.019 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.565037e-01 | 0.019 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.570530e-01 | 0.019 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.572244e-01 | 0.019 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.572244e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.572244e-01 | 0.019 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.578671e-01 | 0.019 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.578671e-01 | 0.019 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.578671e-01 | 0.019 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.585989e-01 | 0.018 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.588653e-01 | 0.018 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.588653e-01 | 0.018 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.588653e-01 | 0.018 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.588653e-01 | 0.018 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.588653e-01 | 0.018 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.598049e-01 | 0.018 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.610792e-01 | 0.017 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.615143e-01 | 0.017 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.615953e-01 | 0.017 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.619121e-01 | 0.017 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.621007e-01 | 0.017 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.621007e-01 | 0.017 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.621007e-01 | 0.017 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.621695e-01 | 0.017 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.641276e-01 | 0.016 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.644227e-01 | 0.016 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.644227e-01 | 0.016 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.647501e-01 | 0.016 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.664406e-01 | 0.015 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.664406e-01 | 0.015 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.670110e-01 | 0.015 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.681019e-01 | 0.014 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.690725e-01 | 0.014 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.692296e-01 | 0.014 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.692296e-01 | 0.014 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.692296e-01 | 0.014 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.692296e-01 | 0.014 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.695633e-01 | 0.013 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.695633e-01 | 0.013 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.695633e-01 | 0.013 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.695633e-01 | 0.013 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.697562e-01 | 0.013 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.701076e-01 | 0.013 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.702999e-01 | 0.013 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.702999e-01 | 0.013 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.716962e-01 | 0.012 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.716962e-01 | 0.012 | 1 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.727257e-01 | 0.012 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.727257e-01 | 0.012 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.727257e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.727257e-01 | 0.012 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.733872e-01 | 0.012 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.733872e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.733872e-01 | 0.012 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.733872e-01 | 0.012 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.733872e-01 | 0.012 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.736213e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.736213e-01 | 0.012 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.739273e-01 | 0.011 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.744595e-01 | 0.011 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.744595e-01 | 0.011 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.756193e-01 | 0.011 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.758233e-01 | 0.011 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.760456e-01 | 0.011 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.764581e-01 | 0.010 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.767745e-01 | 0.010 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.769833e-01 | 0.010 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.769833e-01 | 0.010 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.769833e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.769833e-01 | 0.010 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.769833e-01 | 0.010 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.769833e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.769833e-01 | 0.010 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.781393e-01 | 0.010 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.781393e-01 | 0.010 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.781741e-01 | 0.010 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.790406e-01 | 0.009 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.793226e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.794766e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.794766e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.796692e-01 | 0.009 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.800937e-01 | 0.009 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.800937e-01 | 0.009 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.800937e-01 | 0.009 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.800937e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.818727e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.818727e-01 | 0.008 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.818727e-01 | 0.008 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.818727e-01 | 0.008 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.818727e-01 | 0.008 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.818727e-01 | 0.008 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.818727e-01 | 0.008 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.825191e-01 | 0.008 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.825191e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.835801e-01 | 0.007 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.839962e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.839962e-01 | 0.007 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.843809e-01 | 0.007 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.850345e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.851106e-01 | 0.007 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.851106e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.851106e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.851106e-01 | 0.007 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.851106e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.851106e-01 | 0.007 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.851106e-01 | 0.007 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.856592e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.856592e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.858475e-01 | 0.006 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.858770e-01 | 0.006 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.858770e-01 | 0.006 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.858770e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.858770e-01 | 0.006 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.859696e-01 | 0.006 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.862489e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.868350e-01 | 0.006 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.871230e-01 | 0.006 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.871230e-01 | 0.006 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.871230e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.871230e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.873374e-01 | 0.006 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.875419e-01 | 0.005 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.875419e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.878488e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.878704e-01 | 0.005 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.887055e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.887055e-01 | 0.005 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.887055e-01 | 0.005 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.888635e-01 | 0.005 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.888635e-01 | 0.005 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.888635e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.888934e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.890148e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.897370e-01 | 0.004 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.897846e-01 | 0.004 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.899070e-01 | 0.004 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.901466e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.903173e-01 | 0.004 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.903689e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.903689e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.903689e-01 | 0.004 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.906616e-01 | 0.004 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.911731e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.911731e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.911731e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.914052e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.914685e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.914685e-01 | 0.004 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.914793e-01 | 0.004 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.914793e-01 | 0.004 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.916708e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.916708e-01 | 0.004 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.916708e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.916708e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.921364e-01 | 0.003 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.921364e-01 | 0.003 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.926655e-01 | 0.003 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.927968e-01 | 0.003 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.927968e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.927968e-01 | 0.003 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.927968e-01 | 0.003 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.928638e-01 | 0.003 | 0 | 0 |
| Translation | R-HSA-72766 | 9.929665e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.929913e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.933834e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.933834e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.941761e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.941761e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.944546e-01 | 0.002 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.946129e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.948641e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.952106e-01 | 0.002 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.953413e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.956091e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.956155e-01 | 0.002 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.959713e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.959713e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.959713e-01 | 0.002 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.959713e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.960357e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.961598e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.962023e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.962464e-01 | 0.002 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.965161e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.965161e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.965161e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.965388e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.965388e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.965388e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.965610e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.968269e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.969264e-01 | 0.001 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.969872e-01 | 0.001 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.969872e-01 | 0.001 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.969872e-01 | 0.001 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.972716e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.973947e-01 | 0.001 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.973947e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.974068e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.976358e-01 | 0.001 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.977470e-01 | 0.001 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.977470e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.977470e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.980518e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.981770e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.981770e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.982113e-01 | 0.001 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.983153e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.983153e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.983153e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.983153e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.983153e-01 | 0.001 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.983211e-01 | 0.001 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.983211e-01 | 0.001 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.983211e-01 | 0.001 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.983998e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.984622e-01 | 0.001 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.985432e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.985432e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.985957e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.986531e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.986531e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.987403e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.987403e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.988878e-01 | 0.000 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.989107e-01 | 0.000 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.990581e-01 | 0.000 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.990581e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.990581e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.990758e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.991162e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.991199e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.991689e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.991855e-01 | 0.000 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.991857e-01 | 0.000 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.992957e-01 | 0.000 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.992957e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.992994e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.993629e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.994098e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994366e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.994404e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.994735e-01 | 0.000 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.994735e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.994735e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.994735e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995097e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.995447e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996565e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996565e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996967e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.997057e-01 | 0.000 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.997116e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997126e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.997577e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997791e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997800e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998098e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.998098e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998134e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998419e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998628e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998652e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998706e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998706e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998706e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.998771e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.998771e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998868e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998887e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998937e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998987e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999046e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999329e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999385e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999406e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999406e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999487e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999495e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999539e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.999556e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.999645e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999663e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999668e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999713e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999758e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999781e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999813e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999815e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999836e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999840e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999880e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999897e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999897e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999901e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999908e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999923e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999933e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999942e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999952e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999959e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999960e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999962e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999969e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999974e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999990e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999991e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999991e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999992e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999994e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999994e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.000000e+00 | 0.000 | 1 | 1 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.953993e-14 | 13.709 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.728751e-14 | 13.242 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.936496e-14 | 13.003 | 1 | 1 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.667000e-12 | 11.778 | 1 | 1 |
| Mitotic Anaphase | R-HSA-68882 | 3.282263e-12 | 11.484 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.918199e-12 | 11.407 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.499201e-11 | 10.602 | 1 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.098122e-11 | 10.293 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.777789e-11 | 10.169 | 1 | 1 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.991045e-10 | 9.701 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.860422e-10 | 9.544 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.430954e-10 | 9.465 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.358550e-10 | 9.271 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.695444e-10 | 9.114 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.040254e-09 | 8.983 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.124134e-09 | 8.949 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.846921e-09 | 8.734 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.702255e-09 | 8.568 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.882438e-09 | 8.540 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.718332e-09 | 8.430 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.980286e-09 | 8.303 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.412088e-09 | 8.130 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.100101e-08 | 7.959 | 1 | 1 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.935859e-08 | 7.713 | 1 | 1 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.180898e-08 | 7.661 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.329730e-08 | 7.633 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.972895e-08 | 7.527 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.006368e-08 | 7.397 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.322405e-08 | 7.274 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.212808e-08 | 7.142 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.749078e-08 | 7.111 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.067426e-07 | 6.972 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.152896e-07 | 6.938 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.577927e-07 | 6.802 | 1 | 1 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.359295e-07 | 6.627 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.449739e-07 | 6.352 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.500762e-07 | 6.347 | 1 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.886523e-07 | 6.230 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.239577e-07 | 6.205 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.314465e-07 | 6.200 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.895089e-07 | 6.161 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.570860e-07 | 6.121 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.683117e-07 | 6.114 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.409816e-07 | 6.026 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.407467e-07 | 6.027 | 1 | 1 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.384038e-07 | 6.028 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.131349e-06 | 5.946 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.199612e-06 | 5.921 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.247071e-06 | 5.904 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.119419e-06 | 5.674 | 1 | 1 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.382238e-06 | 5.623 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.881982e-06 | 5.540 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.058396e-06 | 5.515 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.240472e-06 | 5.489 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.240472e-06 | 5.489 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.353957e-06 | 5.474 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.399777e-06 | 5.469 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.638956e-06 | 5.439 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.057390e-06 | 5.392 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.284120e-06 | 5.368 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.442280e-06 | 5.352 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.585728e-06 | 5.253 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.587308e-06 | 5.253 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.011561e-06 | 5.154 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.196100e-06 | 5.143 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.758225e-06 | 5.110 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.075732e-05 | 4.968 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.749167e-05 | 4.757 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.747273e-05 | 4.758 | 1 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.770257e-05 | 4.752 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.964286e-05 | 4.707 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.139396e-05 | 4.670 | 1 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.444677e-05 | 4.612 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.444677e-05 | 4.612 | 1 | 1 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.708443e-05 | 4.567 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.772368e-05 | 4.557 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.840675e-05 | 4.547 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.840675e-05 | 4.547 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.100160e-05 | 4.509 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.376366e-05 | 4.472 | 1 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.668060e-05 | 4.436 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.714679e-05 | 4.430 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.714679e-05 | 4.430 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.984031e-05 | 4.400 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.363108e-05 | 4.360 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.381405e-05 | 4.358 | 1 | 1 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.498424e-05 | 4.347 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.235985e-05 | 4.281 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.134829e-05 | 4.212 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.554180e-05 | 4.183 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.668476e-05 | 4.176 | 1 | 1 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.668476e-05 | 4.176 | 1 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.485940e-05 | 4.126 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.431837e-05 | 4.129 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.599284e-05 | 4.119 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.933321e-05 | 4.049 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.933321e-05 | 4.049 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.130397e-05 | 4.040 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.450952e-05 | 4.025 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.682214e-05 | 4.014 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.046335e-04 | 3.980 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.046335e-04 | 3.980 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.215899e-04 | 3.915 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.273247e-04 | 3.895 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.281296e-04 | 3.892 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.281296e-04 | 3.892 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.503043e-04 | 3.823 | 1 | 1 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.635151e-04 | 3.786 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.526781e-04 | 3.816 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.744061e-04 | 3.758 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.745524e-04 | 3.758 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.817162e-04 | 3.741 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.878337e-04 | 3.726 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.116901e-04 | 3.674 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.112975e-04 | 3.675 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.074895e-04 | 3.683 | 1 | 0 |
| Protein folding | R-HSA-391251 | 2.206674e-04 | 3.656 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.298284e-04 | 3.639 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.554529e-04 | 3.593 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.582229e-04 | 3.588 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.597192e-04 | 3.585 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.995707e-04 | 3.524 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.061653e-04 | 3.514 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.936430e-04 | 3.405 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.939499e-04 | 3.405 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.992772e-04 | 3.399 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.294759e-04 | 3.367 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.322016e-04 | 3.364 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.416723e-04 | 3.355 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.523838e-04 | 3.344 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.549381e-04 | 3.342 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.563559e-04 | 3.341 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.667241e-04 | 3.331 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.847988e-04 | 3.314 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.293969e-04 | 3.276 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.238442e-04 | 3.281 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.555686e-04 | 3.255 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.576745e-04 | 3.254 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.853719e-04 | 3.233 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.120659e-04 | 3.213 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.575993e-04 | 3.182 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.632175e-04 | 3.178 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.734335e-04 | 3.172 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.757016e-04 | 3.170 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.183067e-04 | 3.144 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.351080e-04 | 3.134 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.719914e-04 | 3.112 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.819453e-04 | 3.107 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.919371e-04 | 3.101 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.906303e-04 | 3.102 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.113726e-04 | 3.091 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.522784e-04 | 3.069 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.522784e-04 | 3.069 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.522784e-04 | 3.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.522784e-04 | 3.069 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.780002e-04 | 3.057 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.774749e-04 | 3.057 | 1 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.036549e-04 | 3.044 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.553469e-04 | 3.068 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.818168e-04 | 3.055 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.048385e-04 | 3.043 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.274419e-04 | 3.033 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.274419e-04 | 3.033 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.274419e-04 | 3.033 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.336455e-04 | 3.030 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.793284e-04 | 3.009 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.798216e-04 | 3.009 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.050140e-03 | 2.979 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.066783e-03 | 2.972 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.066783e-03 | 2.972 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.066783e-03 | 2.972 | 1 | 1 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.098532e-03 | 2.959 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.098532e-03 | 2.959 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.119566e-03 | 2.951 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.119566e-03 | 2.951 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.208860e-03 | 2.918 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.214074e-03 | 2.916 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.098532e-03 | 2.959 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.108158e-03 | 2.955 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.289886e-03 | 2.889 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.314933e-03 | 2.881 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.317748e-03 | 2.880 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.346672e-03 | 2.871 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.421694e-03 | 2.847 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.458296e-03 | 2.836 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.458296e-03 | 2.836 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.495670e-03 | 2.825 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.498324e-03 | 2.824 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.535918e-03 | 2.814 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.574008e-03 | 2.803 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.613450e-03 | 2.792 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.671314e-03 | 2.777 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.671314e-03 | 2.777 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.699524e-03 | 2.770 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.699524e-03 | 2.770 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.714607e-03 | 2.766 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.738694e-03 | 2.760 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.771679e-03 | 2.752 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.789664e-03 | 2.747 | 1 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.789664e-03 | 2.747 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.007356e-03 | 2.697 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.948158e-03 | 2.710 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.953138e-03 | 2.709 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.848900e-03 | 2.733 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.789664e-03 | 2.747 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.043946e-03 | 2.690 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.049568e-03 | 2.688 | 1 | 1 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.049568e-03 | 2.688 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.086026e-03 | 2.681 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.098239e-03 | 2.678 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.151941e-03 | 2.667 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.151941e-03 | 2.667 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.235398e-03 | 2.651 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.287657e-03 | 2.641 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.287657e-03 | 2.641 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.327921e-03 | 2.633 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.350073e-03 | 2.629 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.384400e-03 | 2.623 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.451280e-03 | 2.611 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.522119e-03 | 2.598 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.522119e-03 | 2.598 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.608308e-03 | 2.584 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.644223e-03 | 2.578 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.763309e-03 | 2.559 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.943235e-03 | 2.531 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.003090e-03 | 2.522 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.190560e-03 | 2.496 | 1 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.021100e-03 | 2.520 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.914044e-03 | 2.536 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.908861e-03 | 2.536 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.190560e-03 | 2.496 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.819382e-03 | 2.550 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.232629e-03 | 2.490 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.857489e-03 | 2.544 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.281571e-03 | 2.484 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.307942e-03 | 2.480 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.463174e-03 | 2.461 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.463174e-03 | 2.461 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.584229e-03 | 2.446 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.661470e-03 | 2.436 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.661470e-03 | 2.436 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.848898e-03 | 2.415 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.865516e-03 | 2.413 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.865516e-03 | 2.413 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.925221e-03 | 2.406 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.925221e-03 | 2.406 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.939972e-03 | 2.405 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.939972e-03 | 2.405 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.972781e-03 | 2.401 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.078190e-03 | 2.390 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.078190e-03 | 2.390 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.078190e-03 | 2.390 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.143102e-03 | 2.383 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.019238e-03 | 2.299 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.907624e-03 | 2.309 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.907624e-03 | 2.309 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.907624e-03 | 2.309 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.907624e-03 | 2.309 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.907624e-03 | 2.309 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.666318e-03 | 2.331 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.456857e-03 | 2.351 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.675610e-03 | 2.330 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.906671e-03 | 2.309 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.808436e-03 | 2.318 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.019238e-03 | 2.299 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.666318e-03 | 2.331 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.666318e-03 | 2.331 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.124446e-03 | 2.290 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.173691e-03 | 2.286 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.675610e-03 | 2.330 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.666318e-03 | 2.331 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.456857e-03 | 2.351 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.937240e-03 | 2.307 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.124446e-03 | 2.290 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.666318e-03 | 2.331 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.790897e-03 | 2.320 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.406205e-03 | 2.267 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.406205e-03 | 2.267 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.474007e-03 | 2.262 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.476211e-03 | 2.262 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.577843e-03 | 2.254 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.733521e-03 | 2.242 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.908935e-03 | 2.228 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.029219e-03 | 2.220 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.029219e-03 | 2.220 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 6.029219e-03 | 2.220 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.152256e-03 | 2.211 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.152256e-03 | 2.211 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.614201e-03 | 2.180 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.711190e-03 | 2.173 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.828518e-03 | 2.166 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.166448e-03 | 2.145 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.166448e-03 | 2.145 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.394234e-03 | 2.131 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.417193e-03 | 2.130 | 1 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.622861e-03 | 2.118 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.916007e-03 | 2.101 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.939647e-03 | 2.100 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.992566e-03 | 2.097 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.041014e-03 | 2.095 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.097254e-03 | 2.092 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.097254e-03 | 2.092 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.097254e-03 | 2.092 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.097254e-03 | 2.092 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.097254e-03 | 2.092 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.139559e-03 | 2.089 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.444989e-03 | 2.073 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.576100e-03 | 2.067 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.976681e-03 | 2.047 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.062300e-02 | 1.974 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.539893e-03 | 2.020 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.539893e-03 | 2.020 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.213985e-03 | 2.036 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.067030e-02 | 1.972 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.062446e-02 | 1.974 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.062446e-02 | 1.974 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.746782e-03 | 2.058 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.539893e-03 | 2.020 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.352093e-03 | 2.029 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.150265e-03 | 2.039 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.550213e-03 | 2.068 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.330308e-03 | 2.030 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.895164e-03 | 2.005 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.067030e-02 | 1.972 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.062300e-02 | 1.974 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.895164e-03 | 2.005 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.895164e-03 | 2.005 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.117083e-02 | 1.952 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.148159e-02 | 1.940 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.162404e-02 | 1.935 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.162404e-02 | 1.935 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.174098e-02 | 1.930 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.178406e-02 | 1.929 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.178406e-02 | 1.929 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.202983e-02 | 1.920 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.229672e-02 | 1.910 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.229672e-02 | 1.910 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.229672e-02 | 1.910 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.300455e-02 | 1.886 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.300455e-02 | 1.886 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.300455e-02 | 1.886 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.300455e-02 | 1.886 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.307457e-02 | 1.884 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.313118e-02 | 1.882 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.313118e-02 | 1.882 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.315428e-02 | 1.881 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.350229e-02 | 1.870 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.352008e-02 | 1.869 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.410508e-02 | 1.851 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.410508e-02 | 1.851 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.410508e-02 | 1.851 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.436144e-02 | 1.843 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.439788e-02 | 1.842 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.467770e-02 | 1.833 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.468207e-02 | 1.833 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.477865e-02 | 1.830 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.477865e-02 | 1.830 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.477865e-02 | 1.830 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.505551e-02 | 1.822 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.525898e-02 | 1.816 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.539470e-02 | 1.813 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.571183e-02 | 1.804 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.572257e-02 | 1.803 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.582286e-02 | 1.801 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.582286e-02 | 1.801 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.582286e-02 | 1.801 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.603821e-02 | 1.795 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.610719e-02 | 1.793 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.624052e-02 | 1.789 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.624052e-02 | 1.789 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.694728e-02 | 1.771 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.711878e-02 | 1.767 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.720737e-02 | 1.764 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.733803e-02 | 1.761 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.733803e-02 | 1.761 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.733803e-02 | 1.761 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.733803e-02 | 1.761 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.839242e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.839242e-02 | 1.735 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.839242e-02 | 1.735 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.839242e-02 | 1.735 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.839242e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.839242e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.839242e-02 | 1.735 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.061770e-02 | 1.686 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.848319e-02 | 1.733 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.316663e-02 | 1.635 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.919554e-02 | 1.717 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.251522e-02 | 1.648 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.132075e-02 | 1.671 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.831476e-02 | 1.737 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.339226e-02 | 1.631 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.339226e-02 | 1.631 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.339226e-02 | 1.631 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.145770e-02 | 1.668 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.986619e-02 | 1.702 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.780517e-02 | 1.749 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.817053e-02 | 1.741 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.277668e-02 | 1.643 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.239773e-02 | 1.650 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.831476e-02 | 1.737 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.339226e-02 | 1.631 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.339226e-02 | 1.631 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.339226e-02 | 1.631 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.791625e-02 | 1.747 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.132075e-02 | 1.671 | 1 | 1 |
| snRNP Assembly | R-HSA-191859 | 2.365816e-02 | 1.626 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.365816e-02 | 1.626 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.368874e-02 | 1.625 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.453181e-02 | 1.610 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.453181e-02 | 1.610 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.454465e-02 | 1.610 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.468972e-02 | 1.607 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.468972e-02 | 1.607 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.468972e-02 | 1.607 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.571389e-02 | 1.590 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.571389e-02 | 1.590 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.574036e-02 | 1.589 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.602749e-02 | 1.585 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.602749e-02 | 1.585 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.602749e-02 | 1.585 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.602749e-02 | 1.585 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.621990e-02 | 1.581 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.744196e-02 | 1.562 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.744196e-02 | 1.562 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.744196e-02 | 1.562 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.790049e-02 | 1.554 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.790049e-02 | 1.554 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.790049e-02 | 1.554 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.807220e-02 | 1.552 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.807220e-02 | 1.552 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.807220e-02 | 1.552 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.807220e-02 | 1.552 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.895705e-02 | 1.538 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.905938e-02 | 1.537 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.905938e-02 | 1.537 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.024966e-02 | 1.519 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.160330e-02 | 1.500 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.195668e-02 | 1.495 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.195668e-02 | 1.495 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.195668e-02 | 1.495 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.222332e-02 | 1.492 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.248812e-02 | 1.488 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.252038e-02 | 1.488 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.270221e-02 | 1.485 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.270221e-02 | 1.485 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.270221e-02 | 1.485 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.270221e-02 | 1.485 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.326490e-02 | 1.478 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.326490e-02 | 1.478 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.402363e-02 | 1.468 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.409727e-02 | 1.467 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.485837e-02 | 1.458 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.485837e-02 | 1.458 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.507169e-02 | 1.455 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.507169e-02 | 1.455 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.546569e-02 | 1.450 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.575417e-02 | 1.447 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.592843e-02 | 1.445 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.619890e-02 | 1.441 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.619890e-02 | 1.441 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.619890e-02 | 1.441 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.640365e-02 | 1.439 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.640365e-02 | 1.439 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.640365e-02 | 1.439 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.650001e-02 | 1.438 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.653521e-02 | 1.437 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.653521e-02 | 1.437 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.653521e-02 | 1.437 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.653521e-02 | 1.437 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.838185e-02 | 1.416 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.845022e-02 | 1.415 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.845477e-02 | 1.415 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.870599e-02 | 1.412 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.870599e-02 | 1.412 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.951448e-02 | 1.403 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.982496e-02 | 1.400 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.986651e-02 | 1.399 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.986651e-02 | 1.399 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.081134e-02 | 1.389 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.081134e-02 | 1.389 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.468656e-02 | 1.350 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.468656e-02 | 1.350 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 6.439836e-02 | 1.191 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 6.439836e-02 | 1.191 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 6.439836e-02 | 1.191 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 6.439836e-02 | 1.191 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.439836e-02 | 1.191 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.679255e-02 | 1.175 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.654281e-02 | 1.332 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.654281e-02 | 1.332 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.792061e-02 | 1.237 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.818360e-02 | 1.317 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.818360e-02 | 1.317 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.744980e-02 | 1.241 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.744980e-02 | 1.241 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.766531e-02 | 1.170 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.766531e-02 | 1.170 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.766531e-02 | 1.170 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.250126e-02 | 1.204 | 1 | 1 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.250126e-02 | 1.204 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.697389e-02 | 1.244 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.045896e-02 | 1.297 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.573919e-02 | 1.254 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.109365e-02 | 1.292 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.428430e-02 | 1.265 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.266056e-02 | 1.203 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.429769e-02 | 1.192 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.412162e-02 | 1.267 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.697389e-02 | 1.244 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.552306e-02 | 1.342 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.979341e-02 | 1.303 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.646210e-02 | 1.333 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.818360e-02 | 1.317 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.979341e-02 | 1.303 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.677281e-02 | 1.246 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.744980e-02 | 1.241 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.405453e-02 | 1.267 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.818360e-02 | 1.317 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.766531e-02 | 1.170 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.045896e-02 | 1.297 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.513665e-02 | 1.259 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.047765e-02 | 1.297 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.735650e-02 | 1.172 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.679255e-02 | 1.175 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.316374e-02 | 1.200 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.563790e-02 | 1.183 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.439836e-02 | 1.191 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.878964e-02 | 1.312 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.524183e-02 | 1.344 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.174740e-02 | 1.286 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.429769e-02 | 1.192 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.852577e-02 | 1.233 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.826787e-02 | 1.316 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.646210e-02 | 1.333 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.321453e-02 | 1.274 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.112044e-02 | 1.291 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.573919e-02 | 1.254 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.552306e-02 | 1.342 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.654281e-02 | 1.332 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.818360e-02 | 1.317 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.921739e-02 | 1.308 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.979341e-02 | 1.303 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.561002e-02 | 1.341 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.089612e-02 | 1.293 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.250126e-02 | 1.204 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.766531e-02 | 1.170 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.316374e-02 | 1.200 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.798626e-02 | 1.237 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.316374e-02 | 1.200 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.818360e-02 | 1.317 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.211010e-02 | 1.207 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.872558e-02 | 1.163 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.976442e-02 | 1.156 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.058677e-02 | 1.151 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.064471e-02 | 1.151 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.101889e-02 | 1.149 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.101889e-02 | 1.149 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.160362e-02 | 1.145 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.160362e-02 | 1.145 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.160801e-02 | 1.145 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.370251e-02 | 1.133 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.370251e-02 | 1.133 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.646409e-02 | 1.117 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.677926e-02 | 1.115 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.882060e-02 | 1.103 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.940335e-02 | 1.100 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.963396e-02 | 1.099 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.118322e-02 | 1.091 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.118322e-02 | 1.091 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.142583e-02 | 1.089 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.164219e-02 | 1.088 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.289749e-02 | 1.081 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.467247e-02 | 1.072 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.467247e-02 | 1.072 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.467247e-02 | 1.072 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.505623e-02 | 1.070 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 8.518590e-02 | 1.070 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.518590e-02 | 1.070 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 8.518590e-02 | 1.070 | 0 | 0 |
| Translation | R-HSA-72766 | 8.537653e-02 | 1.069 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.570211e-02 | 1.067 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.592656e-02 | 1.066 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.597229e-02 | 1.066 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.028185e-02 | 1.044 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.047916e-02 | 1.043 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.047916e-02 | 1.043 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.047916e-02 | 1.043 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.102852e-02 | 1.041 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.158816e-02 | 1.038 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.158816e-02 | 1.038 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 9.422790e-02 | 1.026 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.422790e-02 | 1.026 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.441804e-02 | 1.025 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.441804e-02 | 1.025 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.526475e-02 | 1.021 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.667955e-02 | 1.015 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.667955e-02 | 1.015 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.667955e-02 | 1.015 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.667955e-02 | 1.015 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.667955e-02 | 1.015 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.733207e-02 | 1.012 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 9.756162e-02 | 1.011 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 9.756162e-02 | 1.011 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.756162e-02 | 1.011 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 9.756162e-02 | 1.011 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 9.756162e-02 | 1.011 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 9.756162e-02 | 1.011 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 9.756162e-02 | 1.011 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.756162e-02 | 1.011 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 9.756162e-02 | 1.011 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 9.756162e-02 | 1.011 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 9.756162e-02 | 1.011 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 9.756162e-02 | 1.011 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 9.756162e-02 | 1.011 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 9.756162e-02 | 1.011 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 9.756162e-02 | 1.011 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 9.756162e-02 | 1.011 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 9.756162e-02 | 1.011 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 9.756162e-02 | 1.011 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.782576e-02 | 1.010 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.993344e-02 | 1.000 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.994524e-02 | 1.000 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 9.994524e-02 | 1.000 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.994524e-02 | 1.000 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.003167e-01 | 0.999 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.003167e-01 | 0.999 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.003167e-01 | 0.999 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.003167e-01 | 0.999 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.010558e-01 | 0.995 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.027151e-01 | 0.988 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.027151e-01 | 0.988 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.028494e-01 | 0.988 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.038678e-01 | 0.984 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.038678e-01 | 0.984 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.038678e-01 | 0.984 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.038678e-01 | 0.984 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.050896e-01 | 0.978 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.074041e-01 | 0.969 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.106884e-01 | 0.956 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.107774e-01 | 0.956 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.107774e-01 | 0.956 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.107774e-01 | 0.956 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.108725e-01 | 0.955 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.114924e-01 | 0.953 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.118916e-01 | 0.951 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.125971e-01 | 0.948 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.163910e-01 | 0.934 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.164797e-01 | 0.934 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.176983e-01 | 0.929 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.176983e-01 | 0.929 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.180642e-01 | 0.928 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.180642e-01 | 0.928 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.207451e-01 | 0.918 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.217577e-01 | 0.915 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.229933e-01 | 0.910 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.244312e-01 | 0.905 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.258568e-01 | 0.900 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.260682e-01 | 0.899 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.856102e-01 | 0.731 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.856102e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.856102e-01 | 0.731 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 1.856102e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.856102e-01 | 0.731 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.856102e-01 | 0.731 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.271438e-01 | 0.896 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.271438e-01 | 0.896 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.271438e-01 | 0.896 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.271438e-01 | 0.896 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.271438e-01 | 0.896 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.271438e-01 | 0.896 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.622608e-01 | 0.790 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.622608e-01 | 0.790 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.622608e-01 | 0.790 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.622608e-01 | 0.790 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.274221e-01 | 0.895 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.988366e-01 | 0.702 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.988366e-01 | 0.702 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.988366e-01 | 0.702 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.988366e-01 | 0.702 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.508352e-01 | 0.821 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.362530e-01 | 0.627 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.339270e-01 | 0.873 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.524619e-01 | 0.817 | 1 | 1 |
| Activation of RAC1 | R-HSA-428540 | 2.011472e-01 | 0.696 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.011472e-01 | 0.696 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.323476e-01 | 0.878 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.323476e-01 | 0.878 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.718986e-01 | 0.765 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.276152e-01 | 0.643 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.276152e-01 | 0.643 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.276152e-01 | 0.643 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.477687e-01 | 0.830 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.477687e-01 | 0.830 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.921356e-01 | 0.716 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.921356e-01 | 0.716 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.130693e-01 | 0.671 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.546824e-01 | 0.811 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.546824e-01 | 0.811 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.332725e-01 | 0.875 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.332725e-01 | 0.875 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.690553e-01 | 0.772 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.981282e-01 | 0.703 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.345956e-01 | 0.630 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.472623e-01 | 0.832 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.993605e-01 | 0.700 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.282509e-01 | 0.892 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.533825e-01 | 0.596 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.692451e-01 | 0.771 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.456619e-01 | 0.837 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.805638e-01 | 0.743 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.010303e-01 | 0.697 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.343676e-01 | 0.872 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.541168e-01 | 0.595 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.413984e-01 | 0.850 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.124072e-01 | 0.673 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.124072e-01 | 0.673 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.270316e-01 | 0.644 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.690553e-01 | 0.772 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.282509e-01 | 0.892 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.011472e-01 | 0.696 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.323476e-01 | 0.878 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.993605e-01 | 0.700 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.152145e-01 | 0.667 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.582703e-01 | 0.801 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.275397e-01 | 0.894 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.619160e-01 | 0.791 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.332725e-01 | 0.875 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.339270e-01 | 0.873 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.481170e-01 | 0.605 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.883925e-01 | 0.725 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.160851e-01 | 0.665 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.458337e-01 | 0.609 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.313417e-01 | 0.882 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.614453e-01 | 0.792 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.313417e-01 | 0.882 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.993880e-01 | 0.700 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.988366e-01 | 0.702 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.921356e-01 | 0.716 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.839607e-01 | 0.735 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.988366e-01 | 0.702 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.052490e-01 | 0.688 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.775883e-01 | 0.751 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.314071e-01 | 0.881 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.499237e-01 | 0.602 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.472623e-01 | 0.832 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.997116e-01 | 0.700 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.856102e-01 | 0.731 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.988366e-01 | 0.702 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.477687e-01 | 0.830 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.921356e-01 | 0.716 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.160851e-01 | 0.665 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.345243e-01 | 0.630 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.775883e-01 | 0.751 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.556982e-01 | 0.808 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.359157e-01 | 0.627 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.359157e-01 | 0.627 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.359157e-01 | 0.627 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.578304e-01 | 0.802 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.276756e-01 | 0.894 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.440004e-01 | 0.613 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.209503e-01 | 0.656 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.578304e-01 | 0.802 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.481854e-01 | 0.605 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.367229e-01 | 0.864 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.718986e-01 | 0.765 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.775883e-01 | 0.751 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.706411e-01 | 0.768 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.706411e-01 | 0.768 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.988366e-01 | 0.702 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.276152e-01 | 0.643 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.276152e-01 | 0.643 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.276152e-01 | 0.643 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.476531e-01 | 0.831 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.280875e-01 | 0.892 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.345243e-01 | 0.630 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.257453e-01 | 0.646 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.164308e-01 | 0.665 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.525205e-01 | 0.817 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.955718e-01 | 0.709 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.639102e-01 | 0.785 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.052490e-01 | 0.688 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.361991e-01 | 0.866 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.237259e-01 | 0.650 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.191364e-01 | 0.659 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.271438e-01 | 0.896 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.988366e-01 | 0.702 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.481170e-01 | 0.605 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.289676e-01 | 0.640 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.218931e-01 | 0.654 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.271516e-01 | 0.644 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.754833e-01 | 0.756 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.644238e-01 | 0.784 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.883925e-01 | 0.725 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.837738e-01 | 0.736 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.775883e-01 | 0.751 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.323476e-01 | 0.878 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.130693e-01 | 0.671 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.453036e-01 | 0.838 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.362530e-01 | 0.627 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.477687e-01 | 0.830 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.981459e-01 | 0.703 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.974529e-01 | 0.705 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.587484e-01 | 0.799 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.706411e-01 | 0.768 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.276756e-01 | 0.894 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.988366e-01 | 0.702 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.718986e-01 | 0.765 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.339270e-01 | 0.873 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.345243e-01 | 0.630 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.508352e-01 | 0.821 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.477687e-01 | 0.830 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.472623e-01 | 0.832 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.754833e-01 | 0.756 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.524619e-01 | 0.817 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.282509e-01 | 0.892 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.361991e-01 | 0.866 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.921356e-01 | 0.716 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.546854e-01 | 0.594 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.546854e-01 | 0.594 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.546854e-01 | 0.594 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.546854e-01 | 0.594 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.566110e-01 | 0.591 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.566110e-01 | 0.591 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.566110e-01 | 0.591 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.568992e-01 | 0.590 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.568992e-01 | 0.590 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.575457e-01 | 0.589 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.587327e-01 | 0.587 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.650727e-01 | 0.577 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.650727e-01 | 0.577 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.650727e-01 | 0.577 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.650727e-01 | 0.577 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.650727e-01 | 0.577 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.650727e-01 | 0.577 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.650727e-01 | 0.577 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.650727e-01 | 0.577 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.661225e-01 | 0.575 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.667378e-01 | 0.574 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.725962e-01 | 0.564 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.734620e-01 | 0.563 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.739980e-01 | 0.562 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.739980e-01 | 0.562 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.739980e-01 | 0.562 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.739980e-01 | 0.562 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.743562e-01 | 0.562 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.749765e-01 | 0.561 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.790143e-01 | 0.554 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.790143e-01 | 0.554 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.815278e-01 | 0.550 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 2.821684e-01 | 0.549 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.823240e-01 | 0.549 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.839236e-01 | 0.547 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.854845e-01 | 0.544 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.867263e-01 | 0.543 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.885367e-01 | 0.540 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.921022e-01 | 0.534 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.962184e-01 | 0.528 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.967738e-01 | 0.528 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.998072e-01 | 0.523 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.005587e-01 | 0.522 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.017071e-01 | 0.520 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.017071e-01 | 0.520 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.098883e-01 | 0.509 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.098883e-01 | 0.509 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.116517e-01 | 0.506 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.116517e-01 | 0.506 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.116517e-01 | 0.506 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.116517e-01 | 0.506 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.116517e-01 | 0.506 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.116517e-01 | 0.506 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.116517e-01 | 0.506 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.116517e-01 | 0.506 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.116517e-01 | 0.506 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.116517e-01 | 0.506 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.116517e-01 | 0.506 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.128856e-01 | 0.505 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.169849e-01 | 0.499 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.206417e-01 | 0.494 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.229254e-01 | 0.491 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.317443e-01 | 0.479 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.318487e-01 | 0.479 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.341986e-01 | 0.476 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.353150e-01 | 0.475 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.353150e-01 | 0.475 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.367861e-01 | 0.473 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.367861e-01 | 0.473 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.367861e-01 | 0.473 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.367861e-01 | 0.473 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.367861e-01 | 0.473 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.367861e-01 | 0.473 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.367861e-01 | 0.473 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.373356e-01 | 0.472 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.373356e-01 | 0.472 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.376838e-01 | 0.471 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.376838e-01 | 0.471 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.376838e-01 | 0.471 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.376838e-01 | 0.471 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.376838e-01 | 0.471 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.376838e-01 | 0.471 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.399542e-01 | 0.469 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.433316e-01 | 0.464 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.475879e-01 | 0.459 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.488729e-01 | 0.457 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.488729e-01 | 0.457 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.488729e-01 | 0.457 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.488729e-01 | 0.457 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.488729e-01 | 0.457 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.488729e-01 | 0.457 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.488729e-01 | 0.457 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.488729e-01 | 0.457 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.488729e-01 | 0.457 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.488729e-01 | 0.457 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.488729e-01 | 0.457 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.488729e-01 | 0.457 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.500519e-01 | 0.456 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.517607e-01 | 0.454 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.532545e-01 | 0.452 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.532545e-01 | 0.452 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.637541e-01 | 0.439 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.654027e-01 | 0.437 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.654085e-01 | 0.437 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.654085e-01 | 0.437 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.654085e-01 | 0.437 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.706011e-01 | 0.431 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.706011e-01 | 0.431 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.706011e-01 | 0.431 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.706011e-01 | 0.431 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.712626e-01 | 0.430 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.718311e-01 | 0.430 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.763662e-01 | 0.424 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.797059e-01 | 0.421 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.830259e-01 | 0.417 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.853875e-01 | 0.414 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.853875e-01 | 0.414 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.853875e-01 | 0.414 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.853875e-01 | 0.414 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.853875e-01 | 0.414 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.853875e-01 | 0.414 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.853875e-01 | 0.414 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.892992e-01 | 0.410 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.919011e-01 | 0.407 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.929310e-01 | 0.406 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.929310e-01 | 0.406 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.929310e-01 | 0.406 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.929310e-01 | 0.406 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.935551e-01 | 0.405 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.942152e-01 | 0.404 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.970534e-01 | 0.401 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.987161e-01 | 0.399 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.015056e-01 | 0.396 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.015056e-01 | 0.396 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.015056e-01 | 0.396 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.015056e-01 | 0.396 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.015056e-01 | 0.396 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.015056e-01 | 0.396 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.015056e-01 | 0.396 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.015056e-01 | 0.396 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.115907e-01 | 0.386 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.192822e-01 | 0.377 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.201344e-01 | 0.377 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.201344e-01 | 0.377 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.209794e-01 | 0.376 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.209794e-01 | 0.376 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.209794e-01 | 0.376 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.209794e-01 | 0.376 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.209794e-01 | 0.376 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.253063e-01 | 0.371 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.289334e-01 | 0.368 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.318372e-01 | 0.365 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.389964e-01 | 0.358 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.389964e-01 | 0.358 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.398649e-01 | 0.357 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.401003e-01 | 0.356 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.440307e-01 | 0.353 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.469160e-01 | 0.350 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.469160e-01 | 0.350 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.469160e-01 | 0.350 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.469160e-01 | 0.350 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.469160e-01 | 0.350 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.487619e-01 | 0.348 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.516090e-01 | 0.345 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.545852e-01 | 0.342 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.554808e-01 | 0.342 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.554808e-01 | 0.342 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.554808e-01 | 0.342 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.599129e-01 | 0.337 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.599129e-01 | 0.337 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.599129e-01 | 0.337 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.599129e-01 | 0.337 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 4.599129e-01 | 0.337 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.599129e-01 | 0.337 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.599129e-01 | 0.337 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.599129e-01 | 0.337 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.599129e-01 | 0.337 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.599129e-01 | 0.337 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.613538e-01 | 0.336 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.613538e-01 | 0.336 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.613538e-01 | 0.336 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.731870e-01 | 0.325 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.762146e-01 | 0.322 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.833923e-01 | 0.316 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.833923e-01 | 0.316 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.833923e-01 | 0.316 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.833923e-01 | 0.316 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.887659e-01 | 0.311 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.887659e-01 | 0.311 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.887659e-01 | 0.311 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.887659e-01 | 0.311 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.887659e-01 | 0.311 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.905476e-01 | 0.309 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.905476e-01 | 0.309 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.977396e-01 | 0.303 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.986226e-01 | 0.302 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.986226e-01 | 0.302 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.988709e-01 | 0.302 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.988709e-01 | 0.302 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.988709e-01 | 0.302 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.992228e-01 | 0.302 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.992960e-01 | 0.302 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.050614e-01 | 0.297 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.050614e-01 | 0.297 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.096390e-01 | 0.293 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.126233e-01 | 0.290 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.126233e-01 | 0.290 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 5.126233e-01 | 0.290 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.126233e-01 | 0.290 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.126233e-01 | 0.290 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.126233e-01 | 0.290 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.126233e-01 | 0.290 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.126233e-01 | 0.290 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.126233e-01 | 0.290 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.126233e-01 | 0.290 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.126233e-01 | 0.290 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.126233e-01 | 0.290 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.126233e-01 | 0.290 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.126233e-01 | 0.290 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.126233e-01 | 0.290 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.126233e-01 | 0.290 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.133862e-01 | 0.290 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.145232e-01 | 0.289 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.165005e-01 | 0.287 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.207434e-01 | 0.283 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.207434e-01 | 0.283 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.207434e-01 | 0.283 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.263167e-01 | 0.279 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.318069e-01 | 0.274 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.318069e-01 | 0.274 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.338918e-01 | 0.273 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.374039e-01 | 0.270 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.413815e-01 | 0.266 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.423278e-01 | 0.266 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.465229e-01 | 0.262 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 5.482320e-01 | 0.261 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.482320e-01 | 0.261 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.482320e-01 | 0.261 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.482320e-01 | 0.261 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.483333e-01 | 0.261 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.491047e-01 | 0.260 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.510302e-01 | 0.259 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.513515e-01 | 0.259 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.513515e-01 | 0.259 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.513515e-01 | 0.259 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 5.513515e-01 | 0.259 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 5.513515e-01 | 0.259 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 5.513515e-01 | 0.259 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.513515e-01 | 0.259 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.513515e-01 | 0.259 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.513515e-01 | 0.259 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.513515e-01 | 0.259 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.601922e-01 | 0.252 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.601922e-01 | 0.252 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.601922e-01 | 0.252 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.601922e-01 | 0.252 | 1 | 1 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.601922e-01 | 0.252 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.601922e-01 | 0.252 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.601922e-01 | 0.252 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.601922e-01 | 0.252 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.601922e-01 | 0.252 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.601922e-01 | 0.252 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.601922e-01 | 0.252 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.601922e-01 | 0.252 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.601922e-01 | 0.252 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.601922e-01 | 0.252 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.601922e-01 | 0.252 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.650168e-01 | 0.248 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.674344e-01 | 0.246 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.674344e-01 | 0.246 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.718132e-01 | 0.243 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.718132e-01 | 0.243 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.718132e-01 | 0.243 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.718132e-01 | 0.243 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.765166e-01 | 0.239 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.779383e-01 | 0.238 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.779383e-01 | 0.238 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.798632e-01 | 0.237 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.805531e-01 | 0.236 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.860556e-01 | 0.232 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.872340e-01 | 0.231 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.888715e-01 | 0.230 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.946137e-01 | 0.226 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.946137e-01 | 0.226 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.946137e-01 | 0.226 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.946513e-01 | 0.226 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.999366e-01 | 0.222 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.000962e-01 | 0.222 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.000962e-01 | 0.222 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.031208e-01 | 0.220 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.031208e-01 | 0.220 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.031208e-01 | 0.220 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.031208e-01 | 0.220 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.031208e-01 | 0.220 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.031208e-01 | 0.220 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.031208e-01 | 0.220 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.031208e-01 | 0.220 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.031208e-01 | 0.220 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.031208e-01 | 0.220 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.031208e-01 | 0.220 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.064937e-01 | 0.217 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.064937e-01 | 0.217 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.083309e-01 | 0.216 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.083309e-01 | 0.216 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.083309e-01 | 0.216 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.083309e-01 | 0.216 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.166087e-01 | 0.210 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.166087e-01 | 0.210 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.170222e-01 | 0.210 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.335181e-01 | 0.198 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.335181e-01 | 0.198 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.346848e-01 | 0.197 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 6.346848e-01 | 0.197 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.346848e-01 | 0.197 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.346848e-01 | 0.197 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.377808e-01 | 0.195 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.377808e-01 | 0.195 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.377808e-01 | 0.195 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.377808e-01 | 0.195 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 6.377808e-01 | 0.195 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.377808e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.414577e-01 | 0.193 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.414577e-01 | 0.193 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.418616e-01 | 0.193 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.418616e-01 | 0.193 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.418616e-01 | 0.193 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.418616e-01 | 0.193 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.418616e-01 | 0.193 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.418616e-01 | 0.193 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.418616e-01 | 0.193 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.418616e-01 | 0.193 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.418616e-01 | 0.193 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.418616e-01 | 0.193 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.418616e-01 | 0.193 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.418616e-01 | 0.193 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.433190e-01 | 0.192 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.433190e-01 | 0.192 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.495713e-01 | 0.187 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.495713e-01 | 0.187 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.516186e-01 | 0.186 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.558841e-01 | 0.183 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.561785e-01 | 0.183 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.581197e-01 | 0.182 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.581197e-01 | 0.182 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.581197e-01 | 0.182 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.596281e-01 | 0.181 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.596281e-01 | 0.181 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.596281e-01 | 0.181 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.596281e-01 | 0.181 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.596281e-01 | 0.181 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.617360e-01 | 0.179 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.768227e-01 | 0.170 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.768227e-01 | 0.170 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.768227e-01 | 0.170 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.768227e-01 | 0.170 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.768227e-01 | 0.170 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.768227e-01 | 0.170 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.768227e-01 | 0.170 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.768227e-01 | 0.170 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.768227e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.768227e-01 | 0.170 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.768227e-01 | 0.170 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.768227e-01 | 0.170 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.776209e-01 | 0.169 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.776209e-01 | 0.169 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.776209e-01 | 0.169 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 6.776209e-01 | 0.169 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.776209e-01 | 0.169 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.776209e-01 | 0.169 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.778015e-01 | 0.169 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.803120e-01 | 0.167 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.806419e-01 | 0.167 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.831849e-01 | 0.165 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.831849e-01 | 0.165 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.831849e-01 | 0.165 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.831849e-01 | 0.165 | 1 | 1 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.831849e-01 | 0.165 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.831849e-01 | 0.165 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.831849e-01 | 0.165 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.839124e-01 | 0.165 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.941461e-01 | 0.159 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.941461e-01 | 0.159 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.941461e-01 | 0.159 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.941461e-01 | 0.159 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.962856e-01 | 0.157 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.962856e-01 | 0.157 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.962856e-01 | 0.157 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.053882e-01 | 0.152 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.053882e-01 | 0.152 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.083729e-01 | 0.150 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.083729e-01 | 0.150 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.083729e-01 | 0.150 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.083729e-01 | 0.150 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.083729e-01 | 0.150 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.083729e-01 | 0.150 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.083729e-01 | 0.150 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.083729e-01 | 0.150 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.083729e-01 | 0.150 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.083729e-01 | 0.150 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.083729e-01 | 0.150 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.083729e-01 | 0.150 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.098896e-01 | 0.149 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.098896e-01 | 0.149 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.098896e-01 | 0.149 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.098896e-01 | 0.149 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.117662e-01 | 0.148 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.124799e-01 | 0.147 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.141196e-01 | 0.146 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.183947e-01 | 0.144 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.217638e-01 | 0.142 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.229430e-01 | 0.141 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.229430e-01 | 0.141 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.250330e-01 | 0.140 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.254624e-01 | 0.139 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.262778e-01 | 0.139 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.262778e-01 | 0.139 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.311326e-01 | 0.136 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.345488e-01 | 0.134 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.368447e-01 | 0.133 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.368447e-01 | 0.133 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.368447e-01 | 0.133 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.368447e-01 | 0.133 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.368447e-01 | 0.133 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.368447e-01 | 0.133 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.409157e-01 | 0.130 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.410726e-01 | 0.130 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.458984e-01 | 0.127 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.458984e-01 | 0.127 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.463513e-01 | 0.127 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.503812e-01 | 0.125 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.535352e-01 | 0.123 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.625382e-01 | 0.118 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.625382e-01 | 0.118 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.625382e-01 | 0.118 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.625382e-01 | 0.118 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.625382e-01 | 0.118 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.625382e-01 | 0.118 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.625382e-01 | 0.118 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.625382e-01 | 0.118 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.625382e-01 | 0.118 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.625382e-01 | 0.118 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.627520e-01 | 0.118 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.627520e-01 | 0.118 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.642987e-01 | 0.117 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.642987e-01 | 0.117 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.642987e-01 | 0.117 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.669073e-01 | 0.115 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.701838e-01 | 0.113 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.729162e-01 | 0.112 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.731684e-01 | 0.112 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.749811e-01 | 0.111 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.815299e-01 | 0.107 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.815299e-01 | 0.107 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.815299e-01 | 0.107 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.815299e-01 | 0.107 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 7.815299e-01 | 0.107 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.815299e-01 | 0.107 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.815299e-01 | 0.107 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.815299e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.852802e-01 | 0.105 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.857245e-01 | 0.105 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.857245e-01 | 0.105 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.857245e-01 | 0.105 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.857245e-01 | 0.105 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.857245e-01 | 0.105 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.857245e-01 | 0.105 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.857245e-01 | 0.105 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.857245e-01 | 0.105 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.857245e-01 | 0.105 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.857245e-01 | 0.105 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.857245e-01 | 0.105 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.857245e-01 | 0.105 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.912831e-01 | 0.102 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.912831e-01 | 0.102 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.955329e-01 | 0.099 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.976448e-01 | 0.098 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.035655e-01 | 0.095 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.036218e-01 | 0.095 | 1 | 1 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.036218e-01 | 0.095 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.044435e-01 | 0.095 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.060837e-01 | 0.094 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.066481e-01 | 0.093 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.066481e-01 | 0.093 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.066481e-01 | 0.093 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.066481e-01 | 0.093 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.066481e-01 | 0.093 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.066481e-01 | 0.093 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.066481e-01 | 0.093 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.066481e-01 | 0.093 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.066481e-01 | 0.093 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.066481e-01 | 0.093 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.066481e-01 | 0.093 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.066481e-01 | 0.093 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.066481e-01 | 0.093 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.066481e-01 | 0.093 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.066481e-01 | 0.093 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.066481e-01 | 0.093 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.086733e-01 | 0.092 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.126970e-01 | 0.090 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.126970e-01 | 0.090 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.126970e-01 | 0.090 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.126970e-01 | 0.090 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.161287e-01 | 0.088 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.161287e-01 | 0.088 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.161287e-01 | 0.088 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.168983e-01 | 0.088 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.168983e-01 | 0.088 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.222638e-01 | 0.085 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.255296e-01 | 0.083 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.255296e-01 | 0.083 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.255296e-01 | 0.083 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.257847e-01 | 0.083 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.267405e-01 | 0.083 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.267405e-01 | 0.083 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.267405e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.267405e-01 | 0.083 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.354720e-01 | 0.078 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.354720e-01 | 0.078 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.393528e-01 | 0.076 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.397772e-01 | 0.076 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.397772e-01 | 0.076 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.397907e-01 | 0.076 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.398285e-01 | 0.076 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.425683e-01 | 0.074 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.425683e-01 | 0.074 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.425683e-01 | 0.074 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.425683e-01 | 0.074 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.425683e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.425683e-01 | 0.074 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.425683e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.425683e-01 | 0.074 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.425683e-01 | 0.074 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.425683e-01 | 0.074 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.438616e-01 | 0.074 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.438616e-01 | 0.074 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.520138e-01 | 0.070 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.520138e-01 | 0.070 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.520138e-01 | 0.070 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.520138e-01 | 0.070 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.520138e-01 | 0.070 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.579439e-01 | 0.067 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.579439e-01 | 0.067 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.579439e-01 | 0.067 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.579439e-01 | 0.067 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.579439e-01 | 0.067 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.579439e-01 | 0.067 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.579439e-01 | 0.067 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.579439e-01 | 0.067 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.601646e-01 | 0.065 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.601646e-01 | 0.065 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.601646e-01 | 0.065 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.627872e-01 | 0.064 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.629238e-01 | 0.064 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.629238e-01 | 0.064 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.631588e-01 | 0.064 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.633477e-01 | 0.064 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.633477e-01 | 0.064 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.663478e-01 | 0.062 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.672615e-01 | 0.062 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.694721e-01 | 0.061 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.718187e-01 | 0.060 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.718187e-01 | 0.060 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.718187e-01 | 0.060 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.718187e-01 | 0.060 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.718187e-01 | 0.060 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.718187e-01 | 0.060 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.718187e-01 | 0.060 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.718187e-01 | 0.060 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.718187e-01 | 0.060 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.718187e-01 | 0.060 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.738804e-01 | 0.059 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.738804e-01 | 0.059 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.738804e-01 | 0.059 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.741316e-01 | 0.058 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.782281e-01 | 0.056 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.782281e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.782281e-01 | 0.056 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.836601e-01 | 0.054 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.836601e-01 | 0.054 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.843390e-01 | 0.053 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.843390e-01 | 0.053 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.843390e-01 | 0.053 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 8.843390e-01 | 0.053 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.843390e-01 | 0.053 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.843390e-01 | 0.053 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.843390e-01 | 0.053 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.843390e-01 | 0.053 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.864580e-01 | 0.052 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.869343e-01 | 0.052 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.919003e-01 | 0.050 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.927335e-01 | 0.049 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.927335e-01 | 0.049 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.929760e-01 | 0.049 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.956371e-01 | 0.048 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.956371e-01 | 0.048 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.956371e-01 | 0.048 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.956391e-01 | 0.048 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.041571e-01 | 0.044 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.058321e-01 | 0.043 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.058321e-01 | 0.043 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.058321e-01 | 0.043 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.058321e-01 | 0.043 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.058321e-01 | 0.043 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.061837e-01 | 0.043 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.061837e-01 | 0.043 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.072013e-01 | 0.042 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.080114e-01 | 0.042 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.080114e-01 | 0.042 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.080114e-01 | 0.042 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.089376e-01 | 0.041 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.128639e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.150318e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.150318e-01 | 0.039 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.150318e-01 | 0.039 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.161516e-01 | 0.038 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.161516e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.161516e-01 | 0.038 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.170963e-01 | 0.038 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.175565e-01 | 0.037 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.176459e-01 | 0.037 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.176459e-01 | 0.037 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.176459e-01 | 0.037 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.228259e-01 | 0.035 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.228259e-01 | 0.035 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.228259e-01 | 0.035 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.228259e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.233332e-01 | 0.035 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.233332e-01 | 0.035 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.233332e-01 | 0.035 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.233332e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.233332e-01 | 0.035 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.233332e-01 | 0.035 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.233332e-01 | 0.035 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.242600e-01 | 0.034 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.261650e-01 | 0.033 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.274586e-01 | 0.033 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.274586e-01 | 0.033 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.274586e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.289970e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.289970e-01 | 0.032 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.294895e-01 | 0.032 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.308240e-01 | 0.031 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.308240e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.308240e-01 | 0.031 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.308240e-01 | 0.031 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.308240e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.308240e-01 | 0.031 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.324954e-01 | 0.030 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.342831e-01 | 0.030 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.346994e-01 | 0.029 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.346994e-01 | 0.029 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.362654e-01 | 0.029 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.375832e-01 | 0.028 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.375832e-01 | 0.028 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.375832e-01 | 0.028 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.393714e-01 | 0.027 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.399657e-01 | 0.027 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.402377e-01 | 0.027 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.406091e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.436824e-01 | 0.025 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.436824e-01 | 0.025 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.436824e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.448269e-01 | 0.025 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.448779e-01 | 0.025 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.485197e-01 | 0.023 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.491860e-01 | 0.023 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.491860e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.491860e-01 | 0.023 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.492633e-01 | 0.023 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.493116e-01 | 0.023 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.493116e-01 | 0.023 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.534471e-01 | 0.021 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.541519e-01 | 0.020 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.541519e-01 | 0.020 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.541519e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.541519e-01 | 0.020 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.550255e-01 | 0.020 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.551961e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.586329e-01 | 0.018 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.586329e-01 | 0.018 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.586329e-01 | 0.018 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.586329e-01 | 0.018 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.586329e-01 | 0.018 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.623885e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.625631e-01 | 0.017 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.626761e-01 | 0.017 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.626761e-01 | 0.017 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.626761e-01 | 0.017 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.626761e-01 | 0.017 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.626761e-01 | 0.017 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.640041e-01 | 0.016 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.640041e-01 | 0.016 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.640041e-01 | 0.016 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.661074e-01 | 0.015 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.663244e-01 | 0.015 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.663244e-01 | 0.015 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.663244e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.663244e-01 | 0.015 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.663244e-01 | 0.015 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.672722e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.684275e-01 | 0.014 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.697196e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.697196e-01 | 0.013 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.697482e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.705987e-01 | 0.013 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.722388e-01 | 0.012 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.722388e-01 | 0.012 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.723925e-01 | 0.012 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.723925e-01 | 0.012 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.725865e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.725865e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.725865e-01 | 0.012 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.740003e-01 | 0.011 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.745550e-01 | 0.011 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.752665e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.752665e-01 | 0.011 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.752665e-01 | 0.011 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.776847e-01 | 0.010 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.779612e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.781743e-01 | 0.010 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.781797e-01 | 0.010 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.781797e-01 | 0.010 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.798374e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.798501e-01 | 0.009 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.798666e-01 | 0.009 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.798666e-01 | 0.009 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.798666e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.801830e-01 | 0.009 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.818352e-01 | 0.008 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.818352e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.818352e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.820859e-01 | 0.008 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.820859e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.827992e-01 | 0.008 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.836001e-01 | 0.007 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.836115e-01 | 0.007 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.836115e-01 | 0.007 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.836115e-01 | 0.007 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.841193e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.842450e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.852142e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.862642e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.866602e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.874332e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.875221e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.875221e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.877931e-01 | 0.005 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.879649e-01 | 0.005 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.883734e-01 | 0.005 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.891420e-01 | 0.005 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.891420e-01 | 0.005 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.891420e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.891420e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.891420e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.891420e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.891420e-01 | 0.005 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.902041e-01 | 0.004 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.917966e-01 | 0.004 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.917966e-01 | 0.004 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.919681e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.920269e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.921797e-01 | 0.003 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.928069e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.928069e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.928069e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.929521e-01 | 0.003 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.932934e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.947185e-01 | 0.002 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.952353e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.952454e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.957016e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.965018e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.968442e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.968442e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.969427e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.970442e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.971531e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.971632e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.973033e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.974318e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.976832e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.977564e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.979536e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.979539e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.984658e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.985163e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.985781e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.985864e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.986315e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.987117e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.987516e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.988029e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.989776e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989841e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.990763e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.992492e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.993476e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993933e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.996320e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.996732e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996891e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997053e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997053e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997120e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998027e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998049e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998368e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998556e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998569e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998950e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998950e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999223e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999229e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999480e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999560e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999626e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999703e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999758e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999801e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999801e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999834e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999836e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999921e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999934e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999945e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999955e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999968e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999972e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999976e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999982e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999983e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999991e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999996e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999997e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.000000e+00 | 0.000 | 1 | 1 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.000000e+00 | 0.000 | 1 | 1 |